Mannatech (MTEX) 10-K 15 Mar 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Feb. 29, 2016	Jun. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	MANNATECH INC
Entity Central Index Key	1,056,358
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 38,898,522
Entity Common Stock, Shares Outstanding		2,696,986
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2015

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
ASSETS
Cash and cash equivalents	$ 31,994	$ 27,999
Restricted cash	1,511	1,511
Accounts receivable, net of allowance of $261 and $213 in 2015 and 2014, respectively	369	504
Income tax receivable	4	4
Inventories, net	9,199	10,591
Prepaid expenses and other current assets	2,905	3,069
Deferred commissions	3,443	4,544
Deferred tax assets, net	460	1,141
Total current assets	49,885	49,363
Property and equipment, net	3,848	2,481
Construction in progress	839	1,622
Long-term restricted cash	6,586	7,045
Other assets	3,759	3,567
Long-term deferred tax assets, net	3,725	3,320
Total assets	68,642	67,398
LIABILITIES AND SHAREHOLDERS' EQUITY
Current portion of capital leases	447	901
Accounts payable	2,683	4,252
Accrued expenses	6,221	6,356
Commissions and incentives payable	6,818	7,908
Taxes payable	736	2,578
Current deferred tax liability	84	123
Current notes payable	713	0
Deferred revenue	8,677	10,890
Total current liabilities	26,379	33,008
Capital leases, excluding current portion	612	852
Long-term deferred tax liabilities	24	26
Long-term notes payable	1,069	0
Other long-term liabilities	1,994	2,136
Total liabilities	$ 30,078	$ 36,022
Commitments and contingencies
Shareholders' equity:
Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding	$ 0	$ 0
Common stock, $0.0001 par value, 99,000,000 shares authorized, 2,773,972 shares issued and 2,682,078 shares outstanding as of December 31, 2015 and 2,773,972 shares issued and 2,676,077 shares outstanding as of December 31, 2014	0	0
Additional paid-in capital	40,494	40,672
Retained earnings	8,589	2,750
Accumulated other comprehensive income (loss)	686	(109)
Treasury stock, at average cost, 91,894 shares as of December 31, 2015 and 97,895 shares as of December 31, 2014, respectively	(11,205)	(11,937)
Total shareholders' equity	38,564	31,376
Total liabilities and shareholders' equity	$ 68,642	$ 67,398

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
ASSETS
Accounts receivable, allowance for doubtful accounts	$ 261	$ 213
Shareholders' equity:
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	99,000,000	99,000,000
Common stock, shares issued (in shares)	2,773,972	2,773,972
Common stock, shares outstanding (in shares)	2,682,078	2,676,077
Treasury stock, shares (in shares)	91,894	97,895

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales	$ 180,267	$ 190,081
Cost of sales	34,102	38,350
Gross profit	146,165	151,731
Operating expenses:
Commissions and incentives	72,956	75,240
Selling and administrative expenses	34,458	36,193
Depreciation and amortization	1,793	1,608
Other operating costs	24,814	25,948
Total operating expenses	134,021	138,989
Income from operations	12,144	12,742
Interest income	210	121
Other expense, net	(4,155)	(3,042)
Income before income taxes	8,199	9,821
Income tax provision	(2,360)	(3,325)
Net income	$ 5,839	$ 6,496
Earnings per common share:
Basic (in dollars per share)	$ 2.18	$ 2.44
Diluted (in dollars per share)	$ 2.14	$ 2.40
Weighted-average common shares outstanding:
Basic (in shares)	2,680	2,663
Diluted (in shares)	2,728	2,706

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME [Abstract]
Net income	$ 5,839	$ 6,496
Foreign currency translations gain	815	653
Pension obligations, net of tax provision of $11 and $11 in 2015 and 2014, respectively	(20)	(19)
Comprehensive income	$ 6,634	$ 7,130

CONSOLIDATED STATEMENTS OF COM6

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME [Abstract]
Pension obligations, tax	$ 11	$ 11

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid in Capital [Member]	Retained Earnings (Deficit) [Member]	Accumulated Other Comprehensive Loss [Member]	Treasury Stock [Member]	Total
Balance at Dec. 31, 2013	$ 0	$ 42,592	$ (3,746)	$ (743)	$ (14,651)	$ 23,452
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Charge related to stock-based compensation	0	678	0	0	0	678
Stock option exercises	0	(2,630)	0	0	2,714	84
Tax effect from exercise of stock options - benefit	0	32	0	0	0	32
Foreign currency translation	0	0	0	653	0	653
Pension obligations, net of tax	0	0	0	(19)	0	(19)
Net income	0	0	6,496	0	0	6,496
Balance at Dec. 31, 2014	0	40,672	2,750	(109)	(11,937)	31,376
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Charge related to stock-based compensation	0	592	0	0	0	592
Stock option exercises	0	(704)	0	0	732	28
Tax effect from exercise of stock options - expense	0	(66)	0	0	0	(66)
Foreign currency translation	0	0	0	815	0	815
Pension obligations, net of tax	0	0	0	(20)	0	(20)
Net income	0	0	5,839	0	0	5,839
Balance at Dec. 31, 2015	$ 0	$ 40,494	$ 8,589	$ 686	$ (11,205)	$ 38,564

CONSOLIDATED STATEMENTS OF SHA8

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY [Abstract]
Pension obligations, tax	$ 11	$ 11

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 5,839	$ 6,496
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,793	1,608
Provision for inventory losses	480	2,124
Provision for doubtful accounts	369	579
(Gain) loss on disposal of assets	28	(9)
Stock-based compensation expense	592	678
Deferred income taxes	88	(1,627)
Tax expense (benefit) from exercise of stock options	66	(32)
Changes in operating assets and liabilities:
Accounts receivable	(266)	(713)
Inventories	605	970
Prepaid expenses and other current assets	462	945
Other assets	86	(170)
Deferred commissions	1,031	(1,943)
Accounts payable	(1,562)	(709)
Accrued expenses and other liabilities	(392)	854
Taxes payable	(1,819)	803
Commissions and incentives payable	(969)	(2,102)
Deferred revenue	(2,063)	4,749
Change in restricted cash	18	(3,081)
Net cash provided by operating activities	4,386	9,420
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of property and equipment	(1,979)	(1,534)
Proceeds from sales of assets	0	9
Net cash used in investing activities	(1,979)	(1,525)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from stock options exercised	28	84
Tax benefit (expense) from exercise of stock options	0	32
Proceeds from note payable	1,640	0
Repayment of capital lease obligations	(1,526)	(1,540)
Net cash provided (used) in financing activities	142	(1,424)
Effect of currency exchange rate changes on cash and cash equivalents	1,446	1,133
Net increase in cash and cash equivalents	3,995	7,604
Cash and cash equivalents at the beginning of the year	27,999	20,395
Cash and cash equivalents at the end of the year	31,994	27,999
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Income taxes paid, net	4,659	4,253
Interest paid on capital leases	89	119
Summary of non-cash investing and financing activities:
Assets acquired through financing arrangements	$ 670	$ 2,141

ORGANIZATION AND SUMMARY OF SIG

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2015
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Mannatech, Incorporated (together with its subsidiaries, the “Company”), located in Coppell, Texas, was incorporated in the state of Texas on November 4, 1993 and is listed on the NASDAQ Global Select Market under the symbol “MTEX”. The Company develops, markets, and sells high-quality, proprietary nutritional supplements, topical and skin care and anti-aging products, and weight-management products. We currently sell our products into three regions: (i) North America/South America (the United States, Canada, Colombia and Mexico); (ii) EMEA (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom); and (iii) Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan and Hong Kong). Independent associates (“associates”) purchase the Company’s products at published wholesale prices to either sell to retail customers or for personal use. Members purchase the Company’s products at a discount from published retail prices primarily for personal use. The Company cannot distinguish products sold for personal use from other sales because it is not involved with the products after delivery, other than usual and customary product warranties and returns. Only independent associates are eligible to earn commissions and incentives. Principles of Consolidation The consolidated financial statements and footnotes include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the Company’s consolidated financial statements in accordance with generally accepted accounting principles requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions. The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the consolidated financial statements, Organization and Summary of Significant Accounting Policies Foreign Currency Translation The United States dollar is the functional currency for the majority of the Company’s foreign subsidiaries. As a result, nonmonetary assets and liabilities are translated at their approximate historical rates, monetary assets and liabilities are translated at exchange rates in effect at the end of the year, and revenues and expenses are translated at weighted-average exchange rates for the year. The local currency is the functional currency of our subsidiaries in Japan, Republic of Korea, Taiwan, Norway, Sweden, and Mexico. These subsidiaries’ assets and liabilities are translated into the United States dollars at exchange rates existing at the balance sheet dates, revenues and expenses are translated at weighted-average exchange rates, and shareholders’ equity and intercompany balances are translated at historical exchange rates. The foreign currency translation adjustment is recorded as a separate component of shareholders’ equity and is included in accumulated other comprehensive loss. Transaction losses totaled approximately $4.2 million and $3.0 million, for the years ended December 31, 2015 and 2014, respectively, and are included in other expense, net in the Company’s Consolidated Statements of Operations. Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash proceeds from credit card receivables are received within 24 to 72 hours. As of December 31, 2015 and 2014, credit card receivables were $0.4 million and $1.2 million, respectively, and cash and cash equivalents held in bank accounts in foreign countries totaled $31.3 million and $24.8 million, respectively. The Company invests cash in liquid instruments, such as money market funds and interest bearing deposits. The Company also holds cash in high quality financial institutions and does not believe it has an excessive exposure to credit concentration risk. Restricted Cash The Company is required to restrict cash for: (i) direct selling insurance premiums and credit card sales in the Republic of Korea; (ii) reserve on credit card sales in the United States and Canada; and (iii) Australia building lease collateral. As of December 31, 2015 and 2014, our total restricted cash was $8.1 million and $ Accounts Receivable Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. As of December 31, 2015 and 2014, receivables consisted primarily of amounts due from members and associates. The Company periodically evaluates its receivables for collectability based on historical experience, recent account activities, and the length of time receivables are past due and writes-off receivables when they become uncollectible. At December 31, 2015 and 2014, the Company held an allowance for doubtful accounts of $0.3 million and $0. million Inventories Inventories consist of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. The Company periodically reviews inventories for obsolescence and any inventories identified as obsolete are reserved or written off. Property and Equipment Property and equipment are stated at cost, less accumulated depreciation and amortization computed using the straight-line method over the estimated useful life of each asset. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the improvements. Expenditures for maintenance and repairs are charged to expense as incurred. The cost of property and equipment sold or otherwise retired and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in other operating costs in the accompanying Consolidated Statements of Operations. The estimated useful lives of fixed assets are as follows: Estimated useful life Office furniture and equipment 5 to 7 years Computer hardware and software 3 to 5 years Automobiles 3 to 5 years Leasehold improvements (1) 2 to 10 years (1) Property and equipment are reviewed for impairment whenever an event or change in circumstances indicates that the carrying amount of an asset or group of assets may not be recoverable. The impairment review includes a comparison of future projected cash flows generated by the asset or group of assets with its associated net carrying value. If the net carrying value of the asset or group of assets exceeds expected cash flows (undiscounted and without interest charges), an impairment loss is recognized to the extent the carrying amount of the asset exceeds its fair value. We determined that no impairment indicators existed during the years ended December 31, 2015 and 2014. Other Assets At December 31, 2015 and 2014, other assets were $3.8 million and $3.6 million, respectively. Included in the December 31, 2015 and 2014 balances were deposits for building leases in various locations of $1.9 million and $1.5 million, respectively. Also included in the December 31, 2015 and 2014 balances were $1.6 million and $1.7 million, respectively, representing a deposit with Mutual Aid Cooperative and Consumer in the Republic of Korea, an organization established by the Republic of Korea’s Fair Trade Commission’s approval to compensate and protect consumers who participate ® Notes Payable Notes payable were $1.8 million at December 31, 2015 as a result of funding from a capital financing agreement related to our investment in computer hardware and software and other financing arrangements. At December 31, 2015, the current portion was $0.7 million and the long-term portion was $1.1 million. Other Long-Term Liabilities Other long-term liabilities were $2.0 million and $2.1 million for the years ending December 31, 2015 and 2014. At December 31, 2015 and 2014, we recorded $0.7 million and $0.8 million, respectively, in other long-term liabilities related to uncertain income tax positions (see Note 8, Income Taxes $0.4 million $0.6 Employee Benefit Plans Revenue Recognition and Deferred Commissions The Company’s revenue is derived from sales of individual products, sales of its starter and renewal packs, and shipping fees. Substantially all of the Company’s product and pack sales are made to associates at published wholesale prices and to members at discounted published retail prices. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience. The Company recognizes revenue from shipped packs and products upon receipt by the customer. Corporate-sponsored event revenue is recognized when the event is held. The Company defers certain components of its revenue. At December 31, 2015 and December 31, 2014, the Company’s deferred revenue was $8.7 million and $10.9 million, respectively. During the third quarter of 2013, the Company started a loyalty program through which customers earn loyalty points from qualified automatic orders, which can be applied to future purchases. The Company defers the dollar equivalent in revenue of these points until the points are applied or forfeited, which includes an estimate of the percentage of the unvested loyalty points that are expected to be forfeited. During the third quarter 2014, the Company modified the program to allow loyalty points to vest more quickly. The deferred revenue associated with the loyalty program at December 31, 2015 and December 31, 2014 was $8.1 million and $9.7 million, respectively. Deferred revenue consisted primarily of: (i) sales of packs and products shipped but not received by the customers by the end of the respective period; (ii) revenue from the loyalty program; and (iii) prepaid registration fees from customers planning to attend a future corporate-sponsored event. In total current assets, the Company defers commissions on (i) the sales of packs and products shipped but not received by the customers by the end of the respective period and (ii) the loyalty program. Deferred commissions were $3.4 million and $4.5 million at December 31, 2015 and December 31, 2014, respectively. Loyalty program (in thousands) Loyalty deferred revenue as of January 1, 2014 $ 5,456 Loyalty points forfeited (4,664 ) Loyalty points used (12,348 ) Loyalty points vested 19,580 Loyalty points unvested 1,679 Loyalty deferred revenue as of December 31, 2014 $ 9,703 Loyalty deferred revenue as of January 1, 2015 $ 9,703 Loyalty points forfeited (8,801 ) Loyalty points used (15,077 ) Loyalty points vested 20,403 Loyalty points unvested 1,845 Loyalty deferred revenue as of December 31, 2015 $ 8,073 We estimate a sales return reserve for expected sales refunds based on our historical experience over a rolling six-month period. If actual results differ from our estimated sales return reserve due to various factors, the amount of revenue recorded for each period could be materially affected. Historically, our sales returns have not materially changed through the years, as the majority of our customers who return their merchandise do so within the first 90 days after the original sale. Sales returns have historically averaged 1.5% or less of our gross sales. For the year ended December 31, 2015 our sales return reserve consisted of the following (in thousands) December 31, 2015 Sales reserve as of January 1, 2015 $ 207 Provision related to sales made in current period 1,456 Adjustment related to sales made in prior periods (10 ) Actual returns or credits related to current period (1,319 ) Actual returns or credits related to prior periods (187 ) Sales reserve as of December 31, 2015 $ 147 Shipping and Handling Costs The Company records freight and shipping fees collected from its customers as revenue. The Company records inbound freight as a component of inventory and cost of sales. Commission and Incentive Expenses Associates earn commissions and incentives based on their direct and indirect commissionable net sales over 13 business periods. Each business period equals 28 days. The Company accrues commissions and incentives when earned by associates and pays commissions on product sales three weeks following the business period end and pays commissions on its pack sales five weeks following the business period end. Advertising Expenses The Company expenses advertising and promotions in selling and administrative expenses when incurred. Advertising and promotional expenses were approximately $5.5 million and $4.9 million, for the years ended December 31, 2015 and 2014, respectively. Educational and promotional items, called sales aids, are sold to associates to assist in their sales efforts and are included in inventories and charged to cost of sales when sold. Research and Development Expenses The Company expenses research and development expenses as incurred. Research and development expenses related to new product development, enhancement of existing products, clinical studies and trials, Food and Drug Administration compliance studies, general supplies, internal salaries, third-party contractors, and consulting fees were approximately $1.7 million and $1.6 million, respectively, for the years ended December 31, 2015 and 2014. Salaries and contract labor are included in selling and administrative expenses and all other research and development costs are included in other operating costs. Stock-Based Compensation The Company currently has one active stock-based compensation plan, which was approved by its shareholders at its 2008 Annual Shareholder’s meeting and amended at the 2010, 2012, and 2014 Annual Shareholder meetings. The Company grants stock options to its employees, consultants, and board members with an exercise price equal to the closing price of its common stock on the date of grant with a term no greater than 10 years. The majority of stock options vest over two or three years. Incentive stock options granted to shareholders who own 10% 110% Software Development Costs The Company capitalizes qualifying internal payroll and external contracting and consulting costs related to the development of internal use software that are incurred during the application development stage, which includes design of the software configuration and interfaces, coding, installation, and testing. Costs incurred during the preliminary project along with post-implementation stages of internal use software are expensed as incurred. The Company amortizes such costs over the estimated useful life of the software, which is three to five years once the software is placed in service. Other Operating Costs Other operating costs include travel, accounting/legal/consulting fees, credit card processing fees, banking fees, off-site storage fees, utilities, and other miscellaneous operating expenses. Income Taxes The Company determines the provision for income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income in the period that includes the enactment date. The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the more likely than not criterion for recognition. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being recognized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes both interest and penalties related to uncertain tax positions as part of the income tax provision. Comprehensive Income and Accumulated Other Comprehensive Income (Loss) Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. The Company’s comprehensive income consists of the Company’s net income, foreign currency translation adjustments from its Japan, Republic of Korea, Taiwan, Norway, Sweden and Mexico operations, and changes in the pension obligation for its Japanese employees. Concentration Risk A significant portion of our revenue is derived from five products: NutriVerus ™ ™ , Ū th™ ® ® ® (in thousands, except percentages) 2015 2014 Sales by product % of total net sales Sales by product % of total net sales Advanced Ambrotose ® $ 59,026 32.7 % $ 63,791 33.6 % Ambrotose ® 9,686 5.4 % 10,895 5.7 % NutriVerus ™ 8,541 4.7 % 10,530 5.5 % PLUS™ 8,239 4.6 % 8,923 4.7 % Ū th™ 5, 3.0 % 13,431 7.1 % Total $ 90,886 50.4 % $ 107,571 56.6 % Our business is not currently exposed to customer concentration risk given that no independent associate has ever accounted for more than 10% of our consolidated net sales. Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, investments, receivables, and restricted cash. The Company utilizes financial institutions that the Company considers to be of high credit quality and periodically evaluates the credit rating of such institutions and the allocation of their investments to minimize exposure to credit concentration risk. Fair Value of Financial Instruments The fair value of the Company’s financial instruments, including cash and cash equivalents, restricted cash, time deposits, money market investments, receivables, payables, and accrued expenses, approximate their carrying values due to their relatively short maturities. See Note 3 to our Consolidated Financial Statements, Fair Value

RECENT ACCOUNTING PRONOUNCEMENT

RECENT ACCOUNTING PRONOUNCEMENTS	12 Months Ended
	Dec. 31, 2015
RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	NOTE 2: RECENT ACCOUNTING PRONOUNCEMENTS In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers Revenue Recognition. Revenue from Contracts with Customers (Topic 606) Deferral of the Effective Date Revenue from Contracts with Customers (Topic 606) -Step 1: Identify the contract(s) with a customer. -Step 2: Identify the performance obligations in the contract. -Step 3: Determine the transaction price. -Step 4: Allocate the transaction price to the performance obligations in the contract. -Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. The standard is effective for the Company for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). Early application is permitted for annual reporting periods beginning after December 15, 2016. Management is currently evaluating the impact of the Company’s pending adoption of ASU 2014-09 on the Company’s consolidated financial statements and has not yet determined the method by which the Company will adopt the standard in 2018. In January 2015, the FASB issued ASU No. 2015-01, Income Statement—Extraordinary and Unusual Items In April 2015, the FASB issued ASU No. 2015-05, Intangibles – Goodwill and Other – Internal-Use Software Intangibles – Goodwill and Other – Internal-Use Software In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory In November 2015, the FASB issued ASU No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes, In February of 2016, the FASB Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

FAIR VALUE

FAIR VALUE	12 Months Ended
	Dec. 31, 2015
FAIR VALUE [Abstract]
FAIR VALUE	NOTE 3: FAIR VALUE The Company utilizes fair value measurements to record fair value adjustments to certain financial assets and to determine fair value disclosures. Fair Value Measurements · Level 1—Quoted unadjusted prices for identical instruments in active markets. · Level 2—Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which all observable inputs and significant value drivers are observable in active markets. · Level 3—Model derived valuations in which one or more significant inputs or significant value drivers are unobservable, including assumptions developed by the Company. The primary objective of the Company’s investment activities is to preserve principal while maximizing yields without significantly increasing risk. The investment instruments held by the Company are money market funds and interest bearing deposits for which quoted market prices are readily available. The Company considers these highly liquid investments to be cash equivalents. These investments are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The tables below present the recorded amount of financial assets measured at fair value (in thousands) 2015 Level 1 Level 2 Level 3 Total Assets Money Market Funds – Fidelity, US $ 319 $ — $ — $ 319 Interest bearing deposits – various banks 14,134 — — 14,134 Total $ 14,453 $ — $ — $ 14,453 Amounts included in: Cash and cash equivalents $ 8,281 $ — $ — $ 8,281 Restricted cash 737 — — 737 Long-term restricted cash 5,435 — — 5,435 Total $ 14,453 $ — $ — $ 14,453 2014 Level 1 Level 2 Level 3 Total Assets Money Market Funds – Fidelity, US $ 392 $ — $ — $ 392 Interest bearing deposits – various banks 12,322 — — 12,322 Total $ 12,714 $ — $ — $ 12,714 Amounts included in: Cash and cash equivalents $ 6,159 $ — $ — $ 6,159 Restricted cash 738 — — 738 Long-term restricted cash 5,817 — — 5,817 Total $ 12,714 $ — $ — $ 12,714

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2015
INVENTORIES [Abstract]
INVENTORIES	NOTE 4: INVENTORIES Inventories consist of raw materials, finished goods, and promotional materials. The Company provides an allowance for any slow-moving or obsolete inventories. Inventories as of December 31, 2015 and 2014, consisted of the following (in thousands) 2015 2014 Raw materials $ 1,187 $ 2,118 Finished goods 9,277 10,615 Inventory reserves for obsolescence (1,265 ) (2,142 ) Total $ 9,199 $ 10,591

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Dec. 31, 2015
PROPERTY AND EQUIPMENT [Abstract]
PROPERTY AND EQUIPMENT	NOTE 5: PROPERTY AND EQUIPMENT As of December 31, 2015 and 2014, property and equipment consisted of the following (in thousands) 2015 2014 Office furniture and equipment $ 8,576 $ 8,666 Computer hardware 7,747 7,738 Computer software 47,724 46,791 Automobiles 81 81 Leasehold improvements 12,393 12,270 76,521 75,546 Less accumulated depreciation and amortization (72,673 ) (73,065 ) Property and equipment, net 3,848 2,481 Construction in progress 839 1,622 Total $ 4,687 $ 4,103

CAPITAL LEASE OBLIGATIONS

CAPITAL LEASE OBLIGATIONS	12 Months Ended
	Dec. 31, 2015
CAPITAL LEASE OBLIGATIONS [Abstract]
CAPITAL LEASE OBLIGATIONS	NOTE 6: CAPITAL LEASE OBLIGATIONS As of December 31, 2015 and 2014, the net book value of leased assets was $1.1 1.3 (in thousands) 2016 $ 492 2017 370 2018 205 2019 52 2020 13 Total future minimum lease payments 1,132 Less: Amounts representing interest (effective interest rate 4.74%) (73 ) Present value of minimum lease payments 1,059 Current portion of capital lease obligations 447 Long-term portion of capital lease obligations $ 612

ACCRUED EXPENSES

ACCRUED EXPENSES	12 Months Ended
	Dec. 31, 2015
ACCRUED EXPENSES [Abstract]
ACCRUED EXPENSES	NOTE 7: ACCRUED EXPENSES As of December 31, 2015 and 2014, accrued expenses consisted of the following (in thousands) 2015 2014 Accrued asset purchases $ 277 $ 291 Accrued compensation 1,620 2,180 Accrued royalties 68 105 Accrued sales and other taxes 2,323 1,193 Other accrued operating expenses 562 786 Customer deposits and sales returns 153 211 Accrued travel expenses related to corporate events 271 107 Accrued shipping and handling costs 257 344 Rent expense 76 147 Accrued legal and accounting fees 614 992 $ 6,221 $ 6,356

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2015
INCOME TAXES [Abstract]
INCOME TAXES	NOTE 8: INCOME TAXES The components of the Company’s income before income taxes are attributable to the following jurisdictions for the years ended December 31 (in thousands) 2015 2014 United States $ 769 $ 2,044 Foreign 7,430 7,777 $ 8,199 $ 9,821 The components of the Company’s income tax provision for the years ended December 31 are as follows (in thousand Current provision (benefit): 2015 2014 Federal $ (336 ) $ 2,433 State 21 43 Foreign 2,518 2,547 2,203 5,023 Deferred provision (benefit): Federal 191 (1,792 ) State 72 349 Foreign (106 ) (255 ) 157 (1,698 ) $ 2,360 $ 3,325 A reconciliation of the Company’s effective income tax rate and the United States federal statutory income tax rate is summarized as follows, for the years ended December 31: 2015 2014 Federal statutory income taxes 35.0 % 35.0 % State income taxes, net of federal benefit 1.0 3.5 Difference in foreign and United States tax on foreign operations (14.8 ) (16.1 ) Effect of changes in valuation allowance for net operating loss carryforwards (8.7 ) 14.3 Effect of change in uncertain tax positions (net) (0.2 ) 0.5 Federal Sub-Part F Income from foreign operations 5.1 2.9 Foreign exchange 5.3 (0.3 ) Other 6.2 (5.9 ) 28.9 % 33.9 % For the years ended December 31, 2015 and 2014, the Company’s effective tax rate was 28.9% and 33.9% respectively. For 2015, the effective tax rate was less than what would have been expected if the federal statutory rate was applied to income before taxes. Items decreasing the effective income tax rate included the lower statutory tax rates in foreign jurisdictions compared to the U.S. and a larger mix of foreign income over U.S. income than in prior years. In addition, the rate decreased for an overall reduction in the valuation allowances associated with certain deferred tax assets. For 2014, the effective tax rate was close to what would have been expected if the federal statutory rate was applied to income before taxes. Items increasing the effective income tax rate included the change in the valuation allowances associated with certain deferred tax assets, U.S. federal tax on deemed foreign dividend distribution, and “subpart F income” resulting from controlled foreign corporation operations. Items decreasing the effective income tax rate included the foreign tax credits. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities consisted of the following at December 31 (in thousands) Deferred tax assets: 2015 2014 Current: Deferred revenue $ 567 $ 453 Inventory capitalization 209 171 Inventory reserves 376 762 Accrued expenses 974 697 Other 205 127 Total current deferred tax assets 2,331 2,210 Noncurrent: Depreciation and amortization 1,788 1,867 Net operating loss (1) 5,378 5,842 Deferred royalty 16 28 Non-cash accounting charges related to stock options and warrants 684 628 Accrued expenses 239 350 Foreign tax credit carryover 3,568 3,855 Other 620 506 Total noncurrent deferred tax assets 12,293 13,076 Total deferred tax assets 14,624 15,286 Valuation allowance (9,028 ) (9,745 ) Total deferred tax assets, net of valuation allowance $ 5,596 $ 5,541 Deferred tax liabilities: Current: Prepaid expenses $ 406 $ 413 Deferred commissions 846 769 Other — 10 Total current deferred tax liabilities 1,252 1,192 Noncurrent: Internally-developed software 266 11 Depreciation and amortization 1 2 Sub-Part F income deferred — — Other — 24 Total noncurrent deferred tax liabilities 267 37 Total deferred tax liabilities $ 1,519 $ 1,229 (1) Jurisdiction Gross NOL Tax Effected NOL Expiration Years Colombia $ 64 $ 22 2019 Mexico 8,482 2,545 2020-2024 Norway 249 67 Indefinite Singapore 131 22 Indefinite Sweden 513 113 Indefinite Switzerland 11,371 1,028 2016-2020 Taiwan 7,133 1,213 2016-2024 Ukraine (1) 581 105 Indefinite United States (states) 11,079 277 2016-2032 (1) In addition to net operating loss attributes, the Company has recorded a foreign tax credit carryforward of $3.1 million, which will begin to expire in 2019 and a charitable contribution carryforward of $0.5 million which will expire between years 2016 through 2020. The Company maintains a full valuation against both the foreign tax credits and the charitable contribution carryforward. At December 31, 2015 and 2014, the Company’s valuation allowance was $9.0 million and $9.7 million, respectively. The provisions of ASC Topic 740 require a company to record a valuation allowance when the “more likely than not” criterion for realizing a deferred tax asset cannot be met. A company is to use judgment in reviewing both positive and negative evidence of realizing a deferred tax asset. Furthermore, the weight given to the potential effect of such evidence is commensurate with the extent the evidence can be objectively verified. The valuation allowances presented below (in millions) “more likely than not Country 2015 2014 Mexico $ 2.5 $ 2.7 Norway — 0.1 Sweden 0.1 0.1 Switzerland 1.0 1.2 Taiwan 1.2 1.2 Ukraine (1) 0.1 0.1 United States 4.0 4.3 Other Jurisdictions 0.1 — Total $ 9.0 $ 9.7 (1) At December 31, 2015 and 2014, the Company did not record a provision for any United States or foreign withholding taxes on its undistributed earnings related to its foreign subsidiaries because it is the intention of the Company to reinvest its undistributed earnings indefinitely in its foreign operations. Generally, such earnings become subject to United States income tax upon the remittance of dividends and under certain other circumstances. At December 31, 2015, it is not practicable to estimate the amount of deferred tax liability on such undistributed earnings. Deferred tax assets (liabilities) are classified in the accompanying Consolidated Balance Sheets of December 31 as follows (in thousands) 2015 2014 Current deferred tax assets $ 460 $ 1,141 Noncurrent deferred tax assets 3,725 3,320 Current deferred tax liabilities (84 ) (123 ) Other long-term liabilities (24 ) (26 ) Net deferred tax assets $ 4,077 $ 4,312 On January 1, 2007, the Company adopted FIN 48, which was codified into Topic 740, which prescribes a comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements, uncertain tax positions that it has taken or expects to take on a tax return. Topic 740 requires that a company recognize in its financial statements the impact of tax positions that meet a “more likely than not” threshold, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. As of December 31, 2015, the Company recorded $0.1 million in current liabilities and $0.7 million in other long-term liabilities related to uncertain income tax positions and income tax reserves associated with various audits. At December 31, 2015, the Company had gross tax-affected unrecognized tax benefits of $0.6 million that, if recognized, would impact the effective tax rate. The Company recognizes penalties and interest charges related to unrecognized tax benefits in current tax expense. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows, for the years ended December 31, 2015 and 2014 (in thousands): 2015 2014 Balance as of January 1 $ 803 $ 738 Additions for tax positions related to the current year — 1 Additions for tax positions of prior years — 111 Reductions of tax positions of prior years (71 ) (47 ) Settlements (17 ) — Balance as of December 31 $ 715 $ 803 The Company recognizes interest and/or penalties related to uncertain tax positions in current income tax expense. As of December 31, 2015 and December 31, 2014, the Company had accrued interest and penalties of $0.2 million and $0.1 million in the consolidated balance sheet, of which $26 thousand and $56 thousand were accrued in the consolidated statement of operations. Although it is not reasonably possible to estimate the amount by which unrecognized tax benefits may increase or decrease within the next twelve months due to uncertainties regarding the timing of any examinations, the Company expects its unrecognized tax benefits to decrease by $0.1 million due to the lapse of statutes of limitations during the next twelve months. The Company files income tax returns in the United States federal jurisdiction and various state and foreign jurisdictions. As of December 31, 2015, the tax years that remained subject to examination by a major tax jurisdiction for the Company’s most significant subsidiaries were as follows: Jurisdiction Open Years Australia 2011-2015 Canada 2011-2015 Denmark 2012-2015 Japan 2012-2015 Mexico 2011-2015 Norway 2009-2015 Republic of Korea 2010-2015 Singapore 2011-2015 South Africa 2012-2015 Sweden 2010-2015 Switzerland 2010-2015 Taiwan 2010-2015 United Kingdom 2009-2015 United States 2012-2015

TRANSACTIONS WITH RELATED PARTI

TRANSACTIONS WITH RELATED PARTIES AND AFFILIATES	12 Months Ended
	Dec. 31, 2015
TRANSACTIONS WITH RELATED PARTIES AND AFFILIATES [Abstract]
TRANSACTIONS WITH RELATED PARTIES AND AFFILIATES	NOTE 9: TRANSACTIONS WITH RELATED PARTIES AND AFFILIATES For the year ended December 31, 2015, the Company made cash donations of $0.9 million, $0.5 million of which was accrued at December 31, 2014, to the M5M Foundation, a 501(c)(3) charitable organization that works to combat the epidemic of childhood malnutrition on a global scale. Several of the Company’s directors and officers and their family members serve on the board of the M5M Foundation, including: · Al Bala, the Company’s President; · Chris Simons, the Company’s Regional Vice President EMEA/North America; · Landen Fredrick, son of J. Stanley Fredrick, the Company’s Chairman of the Board and a major shareholder; and · Lorrie Fry, the daughter of Larry Jobe (a member of our Board). During 2015, we paid employment compensation of approximately $251,000 in salary, bonus, auto allowance, and other compensation to Landen Fredrick, son of J. Stanley Fredrick, the Company’s Chairman of the Board and a major shareholder. In addition, Landen Fredrick participated in the employee health care benefit plans available to all employees of the Company. Landen Fredrick has served as Senior Vice President, Supply Chain and IT since August of 2015. Prior to that, Mr. Fredrick served as Vice President, Global Operations since May of 2013, Vice President, North American Sales and Operations since January of 2011, as Vice President, North American Sales since February of 2010 and as Senior Director of Tools and Training since his hire in May of 2006. Landen Fredrick also serves on the Board of the M5M Foundation. Mr. Ray Robbins is a member of the Company’s Board of Directors and a major shareholder. Mr. Robbins holds positions in the Company’s associate global downline network marketing system. In addition, several of Mr. Robbins’ family members are independent associates. The Company pays commissions and incentives to its independent associates and during 2015 and 2014, the Company paid aggregate commissions and incentives to Mr. Robbins and his family of approximately $3.2 million and $2.9 million, respectively. The aggregate amount of commission and incentives paid to Mr. Robbins was approximately $2.9 million and $2.6 million in 2015 and 2014, respectively. The aggregate amount of commission and incentives paid to family members was approximately $0.3 million in each of 2015 and 2014, of which $0.2 million was paid each year to his son, Kevin Robbins, and $0.1 million was paid each year to his daughter, Marla Finley, and daughter-in-law, Demra Robbins, who both share an account. All commissions and incentives paid to Mr. Robbins and his family members are in accordance with the Company’s global associate career and compensation plan. The Company has also contracted with a software development firm owned by Ryan Robbins, the son of Mr. Ray Robbins. The value of services performed during 2015 were less than $0.1 million. Johanna Bala, the wife of Al Bala, the Company’s Chief Executive Officer and President, is an independent associate who earns commissions and incentives. The aggregate amount of commission and incentives paid to Johanna Bala was approximately $0.2 million in each of 2015 and 2014. Mr. Samuel Caster is the Company’s founder and former Chairman of the Board. Prior to January 2014, Mr. Caster’s beneficial ownership of the Company was approximately 18%, but in January 2014 fell below 5%. Mr. Caster founded MannaRelief in 1999 and served as its Chairman from 1999 through August 2007. MannaRelief employs William A. Mullens, Mr. Caster’s brother-in-law, as its Executive Director. Mr. Caster’s wife, Linda Caster, serves as MannaRelief’s Chairman of the Board. MannaRelief is a 501(c)(3) charitable organization that provides charitable services for children. MannaRelief is not owned or operated by the Company. The Company discontinued supporting MannaRelief in the second quarter of 2014. Historically, the Company made cash donations to MannaRelief, sold products to MannaRelief at cost plus shipping and handling charges, and shipped products purchased by MannaRelief to its chosen recipients. The Company made cash donations and sold products to MannaRelief as follows: 2015 2014 Sold Products $ — million $ 0.3 million Contributed Cash Donations $ — million $ 0.3 million Beginning on December 1, 2011, the Company entered into a series of successive Consulting Agreements with WonderEnterprises, LLC (f/k/a Salinda Enterprises, LLC; hereinafter “Wonder”), where the Company paid Wonder for consulting services performed by Mr. Caster plus reimbursable expenses. Mr. Caster is the owner and an employee of Wonder. For the year ended December 31, 2014, Mr. Caster received $0.1 million for consulting services under these Consulting Agreements. Pursuant to the termination of the final Consulting Agreement according to its terms on February 28, 2014, Mr. Caster is no longer serving as a consultant for the Company.

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	12 Months Ended
	Dec. 31, 2015
EMPLOYEE BENEFIT PLANS [Abstract]
EMPLOYEE BENEFIT PLANS	NOTE 10: EMPLOYEE BENEFIT PLANS Employee Retirement Plan Effective May 9, 1997, the Company adopted a Defined Contribution 401(k) and Profit Sharing Plan (the “401(k) Plan”) for its United States and Canada employees. The 401(k) Plan covers all regular full-time and part-time employees who have completed three months of service and attained the age of twenty-one. United States employees can contribute up to 100 percent of their annual compensation but are limited to the maximum annual dollar amount allowable under the Internal Revenue Code. The 401(k) plan permits matching and discretionary employer contributions. The Company’s matching contributions for its United States and Canada employees vest ratably over a five-year period. During each of the years ended December 31, 2015 and 2014, the Company contributed approximately $0.2 million to the 401(k) Plan for matching contributions. The Company also sponsors a non-U.S. defined benefit plan covering its employees in its Japan subsidiary (the “Benefit Plan”). Benefits under the Benefit Plan are based on a point system for position grade and years of service. The Company utilizes actuarial methods. Inherent in the application of these actuarial methods are key assumptions, including, but not limited to, discount rates and expected long-term rates of return on plan assets. Changes in the related Benefit Plan costs may occur in the future due to changes in the underlying assumptions, changes in the number and composition of plan participants, and changes in the level of benefits provided. The Company uses a measurement date of December 31 to evaluate and record any post-retirement benefits related to the Benefit Plan. Projected Benefit Obligation and Fair Value of Plan Assets The Benefit Plan’s projected benefit obligation and valuation of plan assets were as follows for the years ended December 31 (in thousands) Projected benefit obligation: 2015 2014 Balance, beginning of year $ 549 $ 629 Service cost 75 88 Interest cost 3 3 Liability losses (4 ) (6 ) Benefits paid to participants (141 ) (122 ) Special termination benefit — 34 Foreign currency (3 ) (77 ) Balance, end of year $ 479 $ 549 Plan assets: 2015 2014 Fair value, beginning of year $ — $ — Company contributions 141 122 Benefits paid to participants (141 ) (122 ) Fair value, end of year $ — $ — Funded status of the Benefit Plan as of December 31 (in thousands) 2015 2014 Benefit obligation $ (479 ) $ (549 ) Fair value of plan assets — — Excess of benefit obligation over fair value of plan assets $ (479 ) $ (549 ) Amounts recognized in the accompanying Consolidated Balance Sheets consist of, as of December 31 (in thousands) 2015 2014 Accrued benefit liability $ (479 ) $ (549 ) Transition obligation and unrealized gain (339 ) (372 ) Net amount recognized in the consolidated balance sheets $ (818 ) $ (921 ) Years Ended December 31, Other changes recognized in comprehensive income (loss) (in thousands): 2015 2014 Net periodic cost $ 43 $ 85 Current year gain (4 ) (6 ) Amortization of transition obligation (4 ) (4 ) Total recognized in other comprehensive income (loss) (8 ) (10 ) Total recognized in comprehensive income (loss) $ 35 $ 75 As of December 31, Amounts not yet reflected in net periodic benefit cost and included in accumulated other comprehensive gain (loss) (in thousands) 2015 2014 Transition obligation $ 22 $ 13 Prior service cost 313 353 Net actuarial gain 4 6 Total recognized in accumulated other comprehensive gain (loss) $ 339 $ 372 2016 estimated amounts of amortized transition obligation (in thousands): 2016 Transition obligation $ (4 ) As of December 31, Aggregate Benefit Plan information and accumulated benefit obligation in excess of plan assets (in thousands): 2015 2014 Projected benefit obligation $ 479 $ 549 Accumulated benefit obligation 479 549 Fair value of plan assets — — The weighted-average assumptions to determine the benefit obligation and net cost are as follows: 2015 2014 Discount rate 0.40 % 0.50 % Rate of increase in compensation levels — % — % Components of Expense Pension expense for the Benefit Plan is included in selling, general and administrative expenses in the Consolidated Statements of Operations and is comprised of the following for the years ended December 31 (in thousands) 2015 2014 Service cost $ 75 $ 88 Interest cost 3 3 Amortization of transition obligation 4 4 Gain — — Special termination — 34 Prior service cost (39 ) (44 ) Benefit adjustment — — Total pension expense $ 43 $ 85 Estimated Benefits and Contributions The Company expects to contribute approximately $53,000 to the Benefit Plan in 2016. As of December 31, 2015, benefits expected to be paid by the Benefit Plan for the next ten years is approximately as follows (in thousands) 2016 $ 53 2017 52 2018 49 2019 49 2020 43 Next five years 368 Total expected benefits to be paid $ 614

STOCK OPTION PLAN

STOCK OPTION PLAN	12 Months Ended
	Dec. 31, 2015
STOCK OPTION PLAN [Abstract]
STOCK OPTION PLAN	NOTE 11: STOCK OPTION PLAN Summary of Stock Plan The Company currently has one active stock-based compensation plan, which was approved by shareholders. The Company grants stock options to employees, consultants, and board members at the fair value of its common stock on the date of grant, with a term no greater than ten years. The majority of stock options vest over two or three years. Shareholders who own 10% or more of the Company’s outstanding stock are granted incentive stock options at an exercise price that may not be less than 110% of the fair market value of the Company’s common stock on the date of grant and have a term no greater than five years. In February 2008, the Company’s Board of Directors approved the Mannatech, Incorporated 2008 Stock Incentive Plan (as amended, the “2008 Plan”), which reserved up to 100,000 (as adjusted for a 1-for-10 reverse stock split) shares of common stock for issuance of stock options and restricted stock to our employees, board members, and consultants, plus any shares reserved under the Company’s then-existing, unexpired stock plans for which options had not yet been issued, and any shares underlying outstanding options under the then-existing stock option plans that terminate without having been exercised in full. The 2008 Plan was approved by the Company’s shareholders at the 2008 Annual Shareholders’ Meeting and was amended at the 2012 Annual Shareholders’ Meeting to increase the number of shares of common stock subject to the plan by 100,000 and amended again at the 2014 Annual Shareholder Meeting to increase the number of shares of common stock subject to the plan by an additional 130,000. As of December 31, 2015, the 2008 Plan had 127,124 stock options available for grant before the plan expires on February 20, 2018. A summary of changes in stock options outstanding during the year ended December 31, 2015, is as follows: 2015 Numberof Options (in thousands) Weighted average exercise price Weighted average remaining contractual life (in years) Aggregate intrinsic value (in thousands) Outstanding at beginning of year 249 16.71 Granted 37 19.18 Exercised (5 ) 5.72 Forfeited or expired (55 ) 19.78 Outstanding at end of year 226 16.61 7.09 505 Options exercisable at year end 148 16.95 6.34 282 During 2015, the Company issued 5,001 new shares upon the exercise of options, and the Company granted 1,000 new shares to a member of the Board. Options exercised during the year ending December 31, 2015 had a total intrinsic value, calculated as the difference between the exercise date stock price and the exercise price of less than $0.1 million. Options exercised during the year ending December 31, 2014 had a total intrinsic value of less than $0.2 million. Non-vested shares at December 31, 2015 and 2014 were 77,000 and 121,000, respectively. Valuation and Expense Information Under FASB ASC Topic 718 Compensation – Stock Compensation Under the provisions of FASB ASC Topic 718, the Company is required to measure and recognize compensation expense related to any outstanding and unvested stock options previously granted, and thereafter recognize, in its consolidated financial statements, compensation expense related to any new stock options granted after implementation using a calculated fair-value based option-pricing model. The Company uses the Black-Scholes option-pricing model to calculate the fair value of all of its stock options and its assumptions are based on historical information. The following assumptions were used to calculate the compensation expense and the calculated fair value of stock options granted each year: 2015 2014 Dividend yield: — (1) — (1) Risk-free interest rate: 1.2 – 1.6 % 1.3 - % Expected market price volatility: 79.1 – 80.1 % 77.1 – % Average expected life of stock options: 4.5 years 4.5 years (1) The computation of the expected volatility assumption used in the Black-Scholes calculations for new grants is based on historical volatilities of the Company’s stock. The expected life assumptions are based on the Company’s historical employee exercise and forfeiture behavior. The weighted-average grant-date fair value of stock options granted during the years ended December 31, 2015 and 2014 was $11.90 and $11.25 per share, respectively. The total fair value of shares vested during the years ended December 31, 2015 and 2014 was $0.6 million and $0.1 million, respectively. The Company recorded the following amounts related to the expense of the fair values of options during the years ended December 31, 2015 and 2014 (in thousands) 2015 2014 Selling, general and administrative expenses and income from operations before income taxes $ 575 $ 512 Benefit for income taxes (137 ) (137 ) Effect on net income $ 438 $ 375 As of December 31, 2015, the Company had approximately $0.6 million of total unrecognized compensation expense related to stock options currently outstanding, to be recognized in future years, ending December 31, as follows (in thousands): Total gross unrecognized compensation expense Total tax benefit associated with unrecognized compensation expense Total net unrecognized compensation expense 2016 $ 352 $ 54 $ 298 2017 176 18 158 2018 99 — 99 $ 627 $ 72 $ 555

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2015
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 12: COMMITMENTS AND CONTINGENCIES Operating Leases The Company leases certain office space, automobiles, computer hardware, and warehouse equipment under various non-cancelable operating leases. Some of these leases have renewal options. All of the Company’s leases expire at various times through August 2023. The Company also leases equipment under various month-to-month cancelable operating leases. For the years ended December 31, 2015 and 2014, total rent expense was approximately $3.6 million and $3.9 million, respectively. Approximate future minimum rental commitments for non-cancelable operating leases (in thousands) Years ending December 31, 2016 $ 1,729 2017 1,430 2018 787 2019 297 2020 112 Thereafter — $ 4,355 Purchase Commitments The Company maintains supply agreements with its suppliers and manufacturers. Some of the supply agreements contain exclusivity clauses and/or minimum annual purchase requirements. In March 2006, the Company entered into a ten-year supply agreement to purchase plant-derived mineral nutrition products from IHT Health Products, Inc. (f.k.a. InB:Biotechnologies, Inc.). As of December 31, 2015, the Company is required to purchase an aggregate of $5.0 million through 2016. Royalty and Consulting Agreements The Company utilizes royalty agreements with individuals and entities to provide compensation for items relating to developed products, websites and email provided to our associates. The Company paid royalties of $0.2 million and $0.3 million in 2015 and 2014, respectively. Employment Agreements The Company has non-cancellable employment agreements with certain executives. If the employment relationships with these executives were terminated, as of December 31, 2015, the Company would continue to be indebted to the executives for $1.5 million, payable through 2016.

LITIGATION

LITIGATION	12 Months Ended
	Dec. 31, 2015
LITIGATION [Abstract]
LITIGATION	NOTE 13: LITIGATION Pending Litigation Diana Anselmo and New Day Today Corporation v. Mannatech, Incorporated On February 18, 2015 Ms. Diana Anselmo and New Day Today Corporation (collectively, the “Plaintiffs”) filed suit against Mannatech alleging breach of contract pertaining to a portion of proceeds from a Mannatech Associate position once held by Ms. Anselmo’s former husband, Ray Gebauer. Plaintiffs are seeking damages in excess of $1,000,000 plus legal fees and expenses and a declaration that the Company continue to pay Plaintiffs proceeds from Mr. Gebauer’s former account. The Company retained counsel and Company filed its answer on March 23, 2015 denying Plaintiff’s allegations. The trial was scheduled for March 7, 2016; Mannatech Korea, Ltd. v. Busan Custom Office On or before April 12, 2015, Mannatech Korea, Ltd. filed a suit against the Busan Custom Office (“BCO”) to challenge BCO’s method of calculation regarding its assessment notice issued on July 11, 2013. The assessment notice included an audit of the Company’s imported goods covering fiscal years 2008 through 2012 and required the Company to pay $1.0 million for this assessment, all of which has been accrued to date. The Court ordered both parties to submit a response to its inquiry by January 15, 2016, and upon the response by both parties, the Court will determine whether to issue a decision without additional hearing or conduct additional hearing. This matter remains open. Patent Litigation Mannatech, Incorporated v. Wellness Quest, LLC and Harley Reginald McDaniel On July 11, 2014 the Company filed a patent infringement lawsuit against Wellness Quest, LLC and Dr. H. Reginald McDaniel (“Defendants”) alleging the Defendants infringe United States Patent Nos. 7,157,431 and 7,202,220, both entitled “Compositions of Plant Carbohydrates as Dietary Supplements,” (the “Patents”) and seeking to stop their manufacture, offer, and sale of infringing glyconutritional dietary supplement products. On July 16, 2014, the Company filed a Motion for Preliminary Injunction preventing Defendants from infringing the Patents pending a final decision on the merits. On August 29, 2014, the Defendants filed their Response to Plaintiff’s Motion for Preliminary Injunction and Brief in Support along with their Answer and Affirmative Defenses. On November 4, 2014, the Court denied the Company’s Motion for Preliminary Injunction and Motion to Expedite Discovery. On December 15, 2014, the Company deposed Dr. Reginald McDaniel. Each party submitted its list of claim constructions/definitions and a list of the supporting authority. Each party filed its opening brief and their respective responsive briefs. Defendants have designated an expert and the Company deposed the expert on January 27, 2015 regarding his claim construction opinions while reserving the right to examine him later regarding other matters. The parties remain engaged in the claim construction process. Mediation on this matter was held on April 24, 2015 and a settlement was not reached. On May 12, 2015 the Company received notice of an Order of Transfer advising that the case had been reassigned from Judge Ed Kinkeade to Judge David C. Godbey for all further proceedings. On July 20, 2015, the Court issued its Markman On November 5, 2015 the Court issued an Order accepting Defendant’s stipulation of infringement under the Court’s claim interpretation and granted the Company’s partial motion for summary judgment and issued a permanent injunction against Defendants’ infringement of the Patents. The Court stayed the permanent injunction until the conclusion of Defendants’ appeal to the U.S. Court of Appeals for the Federal Circuit (the “Court of Appeals”). On December 3, 2015, Defendants filed their Notice of Appeal which was docketed by the Court of Appeals on December 8, 2015. This matter remains open. Mannatech, Incorporated v. RBC Life Sciences, Inc. and RBC Life Sciences USA, Inc,. On April 28, 2015 the Company filed a patent infringement lawsuit against RBC Life Sciences, Inc. and RBC Life Sciences USA, Inc. (“Defendants”) alleging the Defendants infringe upon the Patents and seeking to stop their manufacture, offer, and sale of infringing glyconutritional dietary supplement products. The Defendants asserted counterclaims alleging, among other things, invalidity and non-infringement. On May 12, 2015 the Company received notice of an Order of Transfer advising that the case had been reassigned from Judge Ed Kinkeade to Judge David C. Godbey for all further proceedings. The parties filed the Case Management Report with the Court on June 24, 2015. The Company filed its answer to Defendants’ counterclaims on June 29, 2015. Defendants also asserted that they plan to seek re-examination of the Patents with United States Patent and Trademark Office (“USPTO”). The parties reached a settlement on July 28, 2015, and the final judgment and permanent injunction was entered on August 5, 2015. This matter is closed. These lawsuits continue the Company’s enforcement of its patent rights, and the Company intends to vigorously prosecute these matters. Based on the previous successful patent infringement lawsuits against Country Life, LLC, Glycobiotics International, Inc., Techmedica Health, Inc., IonX Holdings, Inc., Boston Mountain Laboratories, Inc., Green Life, LLC, and Xiong Lo and the recent success against RBC Life Sciences, Inc. and RBC Life Sciences USA, Inc. described above, the Company believes there is a strong likelihood that it will obtain permanent injunctions against the manufacture and sale of any infringing products for the duration of the Company’s patents. Investigation of Potential Claims In re: Mannatech, Inc. The Company engaged outside counsel to initiate an investigation regarding certain activities conducted by Samuel L. Caster. On February 12, 2015, the Company petitioned the Court pursuant to Texas Rule of Civil Procedure 202 to depose Mr. Caster to investigate potential claims the Company may have against him. A hearing on the petition was held on March 17, 2015. The Court granted the Company the opportunity to depose Mr. Caster. An Agreed Order was filed with the Court on April 1, 2015. The Company deposed Mr. Caster on April 29, 2015. Following the deposition, the Company moved forward with exercising its rights under the consulting agreement between the Company and Mr. Caster’s company, Wonder, and initiated arbitration proceedings, which are described below. Arbitration Proceeding Mannatech v. Samuel L. Caster and Wonder Enterprises, LLC, Demand for Arbitration, Case No. 01-15-0003-6812 On May 29, 2015 the Company initiated arbitration proceedings against Samuel L. Caster and Wonder (“Respondents”) alleging breach of contract by Mr. Caster and his company, Wonder, in a series of consulting agreements entered into by the parties. Mannatech seeks to recover actual damages, costs of court and prejudgment interest together with disgorgement of all benefits received by Caster and Wonder. The Company estimates its damages to be between $500,000.00 and $3,500,000.00. On June 12, 2015 Respondents contacted the Company’s counsel to request mediation. The parties have agreed to mediate this dispute; mediation was held on August 17, 2015, and a settlement was not reached. A preliminary hearing for arbitration was held on September 18, 2015, and a final hearing will commence on April 25, 2016. A Scheduling Order has been entered and depositions and discovery must be completed by March 25, 2016. The parties are currently engaged in the discovery process. This matter remains open. Trademark Opposition – U.S. Patent and Trademark Office United States Trademark Opposition No. 91221493, Shaklee Corporation v. Mannatech, Incorporated re: UTH On April 15, 2015 the Company received notice that Shaklee Corporation (“Shaklee”) fi led a Notice of Opposition to the Company’s trademark application for UTH (stylized as Ū th On September 15, 2015, Shaklee filed two more Notices of Opposition for the UTH & Design and Ū It is not possible at this time to predict the outcome of this office action or whether the Company will incur any liability, or to estimate the ranges of damages, if any, which may be incurred in connection with this matter. However, the Company believes it has a valid defense and will vigorously defend this claim. This matter will remain open until it is resolved. Litigation in General The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows. The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred or as they become determinable. The outcome of litigation is uncertain, and despite management’s views of the merits of any litigation, or the reasonableness of the Company’s estimates and reserves, the Company’s financial statements could nonetheless be materially affected by an adverse judgment. The Company believes it has adequately reserved for the contingencies arising from current legal matters where an outcome was deemed to be probable, and the loss amount could be reasonably estimated

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2015
SHAREHOLDERS' EQUITY [Abstract]
SHAREHOLDERS' EQUITY	NOTE 14: SHAREHOLDERS’ EQUITY Preferred Stock On May 19, 1998, the Company amended its Amended and Restated Articles of Incorporation to reduce the number of authorized shares of common stock from 100.0 million to 99.0 million and the Company authorized 1.0 million shares of preferred stock with a par value of $0.01 per share. No shares of preferred stock have ever been issued or outstanding. Treasury Stock On June 30, 2004, the Company’s Board of Directors authorized the Company to repurchase, in the open market, the lesser of (i) 131,756 shares of its common stock and (ii) $1.3 million of its shares, (the “June 2004 Plan”). On August 28, 2006, a second program permitting the Company to purchase, in the open market, up to $20 million of its outstanding shares was approved by our Board of Directors (the “August 2006 Plan”). On July 14, 2011, the Company’s Board of Directors authorized the Company to reactivate the June 2004 Plan. As of March 10, 2016, the maximum number of shares available for repurchase under the June 2004 Plan was 19,084, and the total number of shares purchased in the open market under the June 2004 Plan was 112,672. No shares have ever been purchased under the August 2006 Plan. The Company does not have any stock repurchase plans or programs other than the June 2004 Plan and the August 2006 Plan. Equity-Baed Compensation During 2015, 5,001 shares were issued for stock option exercises and 1,000 shares were issued when the Board granted those shares to a member of the Board as compensation for their work on the Board. Accumulated Other Comprehensive Loss Accumulated other comprehensive income (loss) displayed in the Consolidated Statements of Shareholders’ Equity represents the results of certain shareholders’ equity changes not reflected in the consolidated statements of operations, such as foreign currency translation and certain pension and postretirement benefit obligations. The after-tax components of accumulated other comprehensive income (loss), are as follows (in thousands) Foreign Currency Translation Pension Postretirement Benefit Obligation Accumulated Other Comprehensive Loss, Net Balance as of December 31, 2014 $ (457 ) $ 348 $ (109 ) Current-period change before reclassifications 815 — 815 Amounts reclassified from accumulated other comprehensive income (loss) — (31 ) (31 ) Income tax provision — 11 11 Balance as of December 31, 2015 $ 358 $ 328 $ 686

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2015
EARNINGS PER SHARE [Abstract]
EARNINGS PER SHARE	NOTE 15: EARNINGS PER SHARE The Company calculates basic Earnings per Share (EPS) by dividing net income by the weighted-average number of common shares outstanding for the period. The diluted EPS also reflects the potential dilution that could occur if common stock were issued for awards under the 2008 Stock Incentive Plan. In determining potential dilution effect of outstanding stock options during 2015 and 2014, the Company used average common stock close price of $20.17 and $16.66, per share, respectively. Approximately 0.1 million of the Company’s stock options were excluded from the diluted EPS calculation for each of 2015 and 2014 as the effect would have been antidilutive.

SEGMENT INFORMATION

SEGMENT INFORMATION	12 Months Ended
	Dec. 31, 2015
SEGMENT INFORMATION [Abstract]
SEGMENT INFORMATION	NOTE 16: SEGMENT INFORMATION The Company conducts its business as a single operating segment, consolidating all of its business units into a single reportable entity, as a seller of proprietary nutritional supplements, skin care and anti-aging products, and weight-management and fitness products through its network marketing distribution channels operating in twenty-five countries. Each of the Company’s business units sells similar packs and products and possesses similar economic characteristics, such as selling prices and gross margins. In each country, the Company markets its products and pays commissions and incentives in similar market environments. The Company’s management reviews its financial information by country and focuses its internal reporting and analysis of revenues by packs and product sales. The Company sells its products through its independent associates who occupy positions in our network and distribute products through similar distribution channels in each country. No single independent associate has ever accounted for more than 10% of the Company’s consolidated net sales. The Company operates facilities in thirteen countries and sells product in twenty-five countries around the world. These facilities are located in the United States, Canada, Switzerland, Australia, the United Kingdom, Japan, the Republic of Korea (South Korea), Taiwan, South Africa, Mexico, Hong Kong, Singapore and Colombia. Each facility services different geographic areas. We currently sell our products in three regions: (i) North America/South America (the United States, Canada, Colombia and Mexico); (ii) EMEA (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom); (iii) Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan and Hong Kong). Consolidated net sales shipped to customers in these regions, along with pack and product information for the years ended December 31, are as follows (in millions, except percentages) Region 2015 2014 North America $ 73.3 40.7 % $ 80.8 42.5 % Asia/Pacific 91.4 50.7 % 92.4 48.6 % EMEA 15.6 8.6 % 16.9 8.9 % Total $ 180.3 100.0 % $ 190.1 100.0 % 2015 2014 Consolidated product sales $ 143.1 $ 155.3 Consolidated pack sales 31.7 27.8 Consolidated other, including freight 5.5 7.0 Total $ 180.3 $ 190.1 Long-lived assets by region, which include property and equipment and construction in progress for the Company and its subsidiaries, as of December 31, reside in the following regions, as follows (in millions) Region 2015 2014 North America $ 3.5 $ 3.1 Asia/Pacific 1.1 0.8 EMEA 0.1 0.2 Total $ 4.7 $ 4.1 Inventory balances by region, which consist of raw materials, and finished goods, including promotional materials, and offset by obsolete inventories, for the Company and its subsidiaries, reside in the following regions as of December 31, as follows (in millions) Region 2015 2014 North America $ 3.4 $ 4.0 Asia/Pacific 4.3 4.3 EMEA 1.5 2.3 Total $ 9.2 $ 10.6

SCHEDULE II - VALUATION AND QUA

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2015
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS [Abstract]
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	MANNATECH, INCORPORATED AND SUBSIDIARIES (in thousands) Additions Balance at Charged to Charged to Deductions Balance at Year Ended December 31, 2014 Deducted from asset accounts: Allowance for doubtful accounts $ 142 579 — (508 ) $ 213 Allowance for obsolete inventories $ 2,009 2,124 — (1,991 ) $ 2,142 Valuation allowance for deferred tax assets $ 5,264 5,344 — (863 ) $ 9,745 Included in accrued expenses: Reserve for sales returns $ 238 1,628 — (1,659 ) $ 207 Year Ended December 31, 2015 Deducted from asset accounts: Allowance for doubtful accounts $ 213 369 — (321 ) $ 261 Allowance for obsolete inventories $ 2,142 480 — (1,357 ) $ 1,265 Valuation allowance for deferred tax assets $ 9,745 180 — (897 ) $ 9,028 Included in accrued expenses: Reserve for sales returns $ 207 1,446 — (1,506 ) $ 147

ORGANIZATION AND SUMMARY OF S27

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2015
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements and footnotes include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the Company’s consolidated financial statements in accordance with generally accepted accounting principles requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions. The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the consolidated financial statements, Organization and Summary of Significant Accounting Policies
Foreign Currency Translation	Foreign Currency Translation The United States dollar is the functional currency for the majority of the Company’s foreign subsidiaries. As a result, nonmonetary assets and liabilities are translated at their approximate historical rates, monetary assets and liabilities are translated at exchange rates in effect at the end of the year, and revenues and expenses are translated at weighted-average exchange rates for the year. The local currency is the functional currency of our subsidiaries in Japan, Republic of Korea, Taiwan, Norway, Sweden, and Mexico. These subsidiaries’ assets and liabilities are translated into the United States dollars at exchange rates existing at the balance sheet dates, revenues and expenses are translated at weighted-average exchange rates, and shareholders’ equity and intercompany balances are translated at historical exchange rates. The foreign currency translation adjustment is recorded as a separate component of shareholders’ equity and is included in accumulated other comprehensive loss. Transaction losses totaled approximately $4.2 million and $3.0 million, for the years ended December 31, 2015 and 2014, respectively, and are included in other expense, net in the Company’s Consolidated Statements of Operations.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash proceeds from credit card receivables are received within 24 to 72 hours. As of December 31, 2015 and 2014, credit card receivables were $0.4 million and $1.2 million, respectively, and cash and cash equivalents held in bank accounts in foreign countries totaled $31.3 million and $24.8 million, respectively. The Company invests cash in liquid instruments, such as money market funds and interest bearing deposits. The Company also holds cash in high quality financial institutions and does not believe it has an excessive exposure to credit concentration risk.
Restricted Cash	Restricted Cash The Company is required to restrict cash for: (i) direct selling insurance premiums and credit card sales in the Republic of Korea; (ii) reserve on credit card sales in the United States and Canada; and (iii) Australia building lease collateral. As of December 31, 2015 and 2014, our total restricted cash was $8.1 million and $
Accounts Receivable	Accounts Receivable Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. As of December 31, 2015 and 2014, receivables consisted primarily of amounts due from members and associates. The Company periodically evaluates its receivables for collectability based on historical experience, recent account activities, and the length of time receivables are past due and writes-off receivables when they become uncollectible. At December 31, 2015 and 2014, the Company held an allowance for doubtful accounts of $0.3 million and $0. million
Inventories	Inventories Inventories consist of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. The Company periodically reviews inventories for obsolescence and any inventories identified as obsolete are reserved or written off.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation and amortization computed using the straight-line method over the estimated useful life of each asset. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the improvements. Expenditures for maintenance and repairs are charged to expense as incurred. The cost of property and equipment sold or otherwise retired and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in other operating costs in the accompanying Consolidated Statements of Operations. The estimated useful lives of fixed assets are as follows: Estimated useful life Office furniture and equipment 5 to 7 years Computer hardware and software 3 to 5 years Automobiles 3 to 5 years Leasehold improvements (1) 2 to 10 years (1) Property and equipment are reviewed for impairment whenever an event or change in circumstances indicates that the carrying amount of an asset or group of assets may not be recoverable. The impairment review includes a comparison of future projected cash flows generated by the asset or group of assets with its associated net carrying value. If the net carrying value of the asset or group of assets exceeds expected cash flows (undiscounted and without interest charges), an impairment loss is recognized to the extent the carrying amount of the asset exceeds its fair value. We determined that no impairment indicators existed during the years ended December 31, 2015 and 2014.
Other Assets	Other Assets At December 31, 2015 and 2014, other assets were $3.8 million and $3.6 million, respectively. Included in the December 31, 2015 and 2014 balances were deposits for building leases in various locations of $1.9 million and $1.5 million, respectively. Also included in the December 31, 2015 and 2014 balances were $1.6 million and $1.7 million, respectively, representing a deposit with Mutual Aid Cooperative and Consumer in the Republic of Korea, an organization established by the Republic of Korea’s Fair Trade Commission’s approval to compensate and protect consumers who participate ®
Notes Payable	Notes Payable Notes payable were $1.8 million at December 31, 2015 as a result of funding from a capital financing agreement related to our investment in computer hardware and software and other financing arrangements. At December 31, 2015, the current portion was $0.7 million and the long-term portion was $1.1 million.
Other Long-Term Liabilities	Other Long-Term Liabilities Other long-term liabilities were $2.0 million and $2.1 million for the years ending December 31, 2015 and 2014. At December 31, 2015 and 2014, we recorded $0.7 million and $0.8 million, respectively, in other long-term liabilities related to uncertain income tax positions (see Note 8, Income Taxes $0.4 million $0.6 Employee Benefit Plans
Revenue Recognition and Deferred Commissions	Revenue Recognition and Deferred Commissions The Company’s revenue is derived from sales of individual products, sales of its starter and renewal packs, and shipping fees. Substantially all of the Company’s product and pack sales are made to associates at published wholesale prices and to members at discounted published retail prices. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience. The Company recognizes revenue from shipped packs and products upon receipt by the customer. Corporate-sponsored event revenue is recognized when the event is held. The Company defers certain components of its revenue. At December 31, 2015 and December 31, 2014, the Company’s deferred revenue was $8.7 million and $10.9 million, respectively. During the third quarter of 2013, the Company started a loyalty program through which customers earn loyalty points from qualified automatic orders, which can be applied to future purchases. The Company defers the dollar equivalent in revenue of these points until the points are applied or forfeited, which includes an estimate of the percentage of the unvested loyalty points that are expected to be forfeited. During the third quarter 2014, the Company modified the program to allow loyalty points to vest more quickly. The deferred revenue associated with the loyalty program at December 31, 2015 and December 31, 2014 was $8.1 million and $9.7 million, respectively. Deferred revenue consisted primarily of: (i) sales of packs and products shipped but not received by the customers by the end of the respective period; (ii) revenue from the loyalty program; and (iii) prepaid registration fees from customers planning to attend a future corporate-sponsored event. In total current assets, the Company defers commissions on (i) the sales of packs and products shipped but not received by the customers by the end of the respective period and (ii) the loyalty program. Deferred commissions were $3.4 million and $4.5 million at December 31, 2015 and December 31, 2014, respectively. Loyalty program (in thousands) Loyalty deferred revenue as of January 1, 2014 $ 5,456 Loyalty points forfeited (4,664 ) Loyalty points used (12,348 ) Loyalty points vested 19,580 Loyalty points unvested 1,679 Loyalty deferred revenue as of December 31, 2014 $ 9,703 Loyalty deferred revenue as of January 1, 2015 $ 9,703 Loyalty points forfeited (8,801 ) Loyalty points used (15,077 ) Loyalty points vested 20,403 Loyalty points unvested 1,845 Loyalty deferred revenue as of December 31, 2015 $ 8,073 We estimate a sales return reserve for expected sales refunds based on our historical experience over a rolling six-month period. If actual results differ from our estimated sales return reserve due to various factors, the amount of revenue recorded for each period could be materially affected. Historically, our sales returns have not materially changed through the years, as the majority of our customers who return their merchandise do so within the first 90 days after the original sale. Sales returns have historically averaged 1.5% or less of our gross sales. For the year ended December 31, 2015 our sales return reserve consisted of the following (in thousands) December 31, 2015 Sales reserve as of January 1, 2015 $ 207 Provision related to sales made in current period 1,456 Adjustment related to sales made in prior periods (10 ) Actual returns or credits related to current period (1,319 ) Actual returns or credits related to prior periods (187 ) Sales reserve as of December 31, 2015 $ 147
Shipping and Handling Costs	Shipping and Handling Costs The Company records freight and shipping fees collected from its customers as revenue. The Company records inbound freight as a component of inventory and cost of sales.
Commission and Incentive Expenses	Commission and Incentive Expenses Associates earn commissions and incentives based on their direct and indirect commissionable net sales over 13 business periods. Each business period equals 28 days. The Company accrues commissions and incentives when earned by associates and pays commissions on product sales three weeks following the business period end and pays commissions on its pack sales five weeks following the business period end.
Advertising Expenses	Advertising Expenses The Company expenses advertising and promotions in selling and administrative expenses when incurred. Advertising and promotional expenses were approximately $5.5 million and $4.9 million, for the years ended December 31, 2015 and 2014, respectively. Educational and promotional items, called sales aids, are sold to associates to assist in their sales efforts and are included in inventories and charged to cost of sales when sold.
Research and Development Expenses	Research and Development Expenses The Company expenses research and development expenses as incurred. Research and development expenses related to new product development, enhancement of existing products, clinical studies and trials, Food and Drug Administration compliance studies, general supplies, internal salaries, third-party contractors, and consulting fees were approximately $1.7 million and $1.6 million, respectively, for the years ended December 31, 2015 and 2014. Salaries and contract labor are included in selling and administrative expenses and all other research and development costs are included in other operating costs.
Stock-Based Compensation	Stock-Based Compensation The Company currently has one active stock-based compensation plan, which was approved by its shareholders at its 2008 Annual Shareholder’s meeting and amended at the 2010, 2012, and 2014 Annual Shareholder meetings. The Company grants stock options to its employees, consultants, and board members with an exercise price equal to the closing price of its common stock on the date of grant with a term no greater than 10 years. The majority of stock options vest over two or three years. Incentive stock options granted to shareholders who own 10% 110%
Software Development Costs	Software Development Costs The Company capitalizes qualifying internal payroll and external contracting and consulting costs related to the development of internal use software that are incurred during the application development stage, which includes design of the software configuration and interfaces, coding, installation, and testing. Costs incurred during the preliminary project along with post-implementation stages of internal use software are expensed as incurred. The Company amortizes such costs over the estimated useful life of the software, which is three to five years once the software is placed in service.
Other Operating Costs	Other Operating Costs Other operating costs include travel, accounting/legal/consulting fees, credit card processing fees, banking fees, off-site storage fees, utilities, and other miscellaneous operating expenses.
Income Taxes	Income Taxes The Company determines the provision for income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income in the period that includes the enactment date. The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the more likely than not criterion for recognition. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being recognized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes both interest and penalties related to uncertain tax positions as part of the income tax provision.
Comprehensive Income and Accumulated Other Comprehensive Income (Loss)	Comprehensive Income and Accumulated Other Comprehensive Income (Loss) Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. The Company’s comprehensive income consists of the Company’s net income, foreign currency translation adjustments from its Japan, Republic of Korea, Taiwan, Norway, Sweden and Mexico operations, and changes in the pension obligation for its Japanese employees.
Concentration Risk	Concentration Risk A significant portion of our revenue is derived from five products: NutriVerus ™ ™ , Ū th™ ® ® ® (in thousands, except percentages) 2015 2014 Sales by product % of total net sales Sales by product % of total net sales Advanced Ambrotose ® $ 59,026 32.7 % $ 63,791 33.6 % Ambrotose ® 9,686 5.4 % 10,895 5.7 % NutriVerus ™ 8,541 4.7 % 10,530 5.5 % PLUS™ 8,239 4.6 % 8,923 4.7 % Ū th™ 5, 3.0 % 13,431 7.1 % Total $ 90,886 50.4 % $ 107,571 56.6 % Our business is not currently exposed to customer concentration risk given that no independent associate has ever accounted for more than 10% of our consolidated net sales. Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, investments, receivables, and restricted cash. The Company utilizes financial institutions that the Company considers to be of high credit quality and periodically evaluates the credit rating of such institutions and the allocation of their investments to minimize exposure to credit concentration risk.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s financial instruments, including cash and cash equivalents, restricted cash, time deposits, money market investments, receivables, payables, and accrued expenses, approximate their carrying values due to their relatively short maturities. See Note 3 to our Consolidated Financial Statements, Fair Value

ORGANIZATION AND SUMMARY OF S28

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2015
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Estimated useful lives of fixed assets	The estimated useful lives of fixed assets are as follows: Estimated useful life Office furniture and equipment 5 to 7 years Computer hardware and software 3 to 5 years Automobiles 3 to 5 years Leasehold improvements (1) 2 to 10 years (1)
Loyalty deferred revenue	Deferred commissions were $3.4 million and $4.5 million at December 31, 2015 and December 31, 2014, respectively. Loyalty program (in thousands) Loyalty deferred revenue as of January 1, 2014 $ 5,456 Loyalty points forfeited (4,664 ) Loyalty points used (12,348 ) Loyalty points vested 19,580 Loyalty points unvested 1,679 Loyalty deferred revenue as of December 31, 2014 $ 9,703 Loyalty deferred revenue as of January 1, 2015 $ 9,703 Loyalty points forfeited (8,801 ) Loyalty points used (15,077 ) Loyalty points vested 20,403 Loyalty points unvested 1,845 Loyalty deferred revenue as of December 31, 2015 $ 8,073
Sales return reserve	For the year ended December 31, 2015 our sales return reserve consisted of the following (in thousands) December 31, 2015 Sales reserve as of January 1, 2015 $ 207 Provision related to sales made in current period 1,456 Adjustment related to sales made in prior periods (10 ) Actual returns or credits related to current period (1,319 ) Actual returns or credits related to prior periods (187 ) Sales reserve as of December 31, 2015 $ 147
Concentration risk	Revenue from these products were as follows for the years ended December 31, 2015 and 2014 (in thousands, except percentages) 2015 2014 Sales by product % of total net sales Sales by product % of total net sales Advanced Ambrotose ® $ 59,026 32.7 % $ 63,791 33.6 % Ambrotose ® 9,686 5.4 % 10,895 5.7 % NutriVerus ™ 8,541 4.7 % 10,530 5.5 % PLUS™ 8,239 4.6 % 8,923 4.7 % Ū th™ 5, 3.0 % 13,431 7.1 % Total $ 90,886 50.4 % $ 107,571 56.6 %

FAIR VALUE (Tables)

FAIR VALUE (Tables)	12 Months Ended
	Dec. 31, 2015
FAIR VALUE [Abstract]
Fair value, assets measured on recurring basis	The Company did not have any material financial liabilities that were required to be measured at fair value on a recurring basis at December 31, 2015 and 2014. 2015 Level 1 Level 2 Level 3 Total Assets Money Market Funds – Fidelity, US $ 319 $ — $ — $ 319 Interest bearing deposits – various banks 14,134 — — 14,134 Total $ 14,453 $ — $ — $ 14,453 Amounts included in: Cash and cash equivalents $ 8,281 $ — $ — $ 8,281 Restricted cash 737 — — 737 Long-term restricted cash 5,435 — — 5,435 Total $ 14,453 $ — $ — $ 14,453 2014 Level 1 Level 2 Level 3 Total Assets Money Market Funds – Fidelity, US $ 392 $ — $ — $ 392 Interest bearing deposits – various banks 12,322 — — 12,322 Total $ 12,714 $ — $ — $ 12,714 Amounts included in: Cash and cash equivalents $ 6,159 $ — $ — $ 6,159 Restricted cash 738 — — 738 Long-term restricted cash 5,817 — — 5,817 Total $ 12,714 $ — $ — $ 12,714

INVENTORIES (Tables)

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2015
INVENTORIES [Abstract]
Inventories	Inventories as of December 31, 2015 and 2014, consisted of the following (in thousands) 2015 2014 Raw materials $ 1,187 $ 2,118 Finished goods 9,277 10,615 Inventory reserves for obsolescence (1,265 ) (2,142 ) Total $ 9,199 $ 10,591

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2015
PROPERTY AND EQUIPMENT [Abstract]
Property and equipment	As of December 31, 2015 and 2014, property and equipment consisted of the following (in thousands) 2015 2014 Office furniture and equipment $ 8,576 $ 8,666 Computer hardware 7,747 7,738 Computer software 47,724 46,791 Automobiles 81 81 Leasehold improvements 12,393 12,270 76,521 75,546 Less accumulated depreciation and amortization (72,673 ) (73,065 ) Property and equipment, net 3,848 2,481 Construction in progress 839 1,622 Total $ 4,687 $ 4,103

CAPITAL LEASE OBLIGATIONS (Tabl

CAPITAL LEASE OBLIGATIONS (Tables)	12 Months Ended
	Dec. 31, 2015
CAPITAL LEASE OBLIGATIONS [Abstract]
Future minimum lease payments	The future minimum lease payments (in thousands) 2016 $ 492 2017 370 2018 205 2019 52 2020 13 Total future minimum lease payments 1,132 Less: Amounts representing interest (effective interest rate 4.74%) (73 ) Present value of minimum lease payments 1,059 Current portion of capital lease obligations 447 Long-term portion of capital lease obligations $ 612

ACCRUED EXPENSES (Tables)

ACCRUED EXPENSES (Tables)	12 Months Ended
	Dec. 31, 2015
ACCRUED EXPENSES [Abstract]
Accrued expenses	As of December 31, 2015 and 2014, accrued expenses consisted of the following (in thousands) 2015 2014 Accrued asset purchases $ 277 $ 291 Accrued compensation 1,620 2,180 Accrued royalties 68 105 Accrued sales and other taxes 2,323 1,193 Other accrued operating expenses 562 786 Customer deposits and sales returns 153 211 Accrued travel expenses related to corporate events 271 107 Accrued shipping and handling costs 257 344 Rent expense 76 147 Accrued legal and accounting fees 614 992 $ 6,221 $ 6,356

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2015
INCOME TAXES [Abstract]
Income before income taxes	The components of the Company’s income before income taxes are attributable to the following jurisdictions for the years ended December 31 (in thousands) 2015 2014 United States $ 769 $ 2,044 Foreign 7,430 7,777 $ 8,199 $ 9,821
Income tax provision	The components of the Company’s income tax provision for the years ended December 31 are as follows (in thousand Current provision (benefit): 2015 2014 Federal $ (336 ) $ 2,433 State 21 43 Foreign 2,518 2,547 2,203 5,023 Deferred provision (benefit): Federal 191 (1,792 ) State 72 349 Foreign (106 ) (255 ) 157 (1,698 ) $ 2,360 $ 3,325
Reconciliation of effective income tax rate and United States federal statutory income tax rate	A reconciliation of the Company’s effective income tax rate and the United States federal statutory income tax rate is summarized as follows, for the years ended December 31: 2015 2014 Federal statutory income taxes 35.0 % 35.0 % State income taxes, net of federal benefit 1.0 3.5 Difference in foreign and United States tax on foreign operations (14.8 ) (16.1 ) Effect of changes in valuation allowance for net operating loss carryforwards (8.7 ) 14.3 Effect of change in uncertain tax positions (net) (0.2 ) 0.5 Federal Sub-Part F Income from foreign operations 5.1 2.9 Foreign exchange 5.3 (0.3 ) Other 6.2 (5.9 ) 28.9 % 33.9 %
Deferred tax assets and liabilities	Significant components of the Company’s deferred tax assets and liabilities consisted of the following at December 31 (in thousands) Deferred tax assets: 2015 2014 Current: Deferred revenue $ 567 $ 453 Inventory capitalization 209 171 Inventory reserves 376 762 Accrued expenses 974 697 Other 205 127 Total current deferred tax assets 2,331 2,210 Noncurrent: Depreciation and amortization 1,788 1,867 Net operating loss (1) 5,378 5,842 Deferred royalty 16 28 Non-cash accounting charges related to stock options and warrants 684 628 Accrued expenses 239 350 Foreign tax credit carryover 3,568 3,855 Other 620 506 Total noncurrent deferred tax assets 12,293 13,076 Total deferred tax assets 14,624 15,286 Valuation allowance (9,028 ) (9,745 ) Total deferred tax assets, net of valuation allowance $ 5,596 $ 5,541 Deferred tax liabilities: Current: Prepaid expenses $ 406 $ 413 Deferred commissions 846 769 Other — 10 Total current deferred tax liabilities 1,252 1,192 Noncurrent: Internally-developed software 266 11 Depreciation and amortization 1 2 Sub-Part F income deferred — — Other — 24 Total noncurrent deferred tax liabilities 267 37 Total deferred tax liabilities $ 1,519 $ 1,229 (1)
Net operating loss by Jurisdiction	Jurisdiction Gross NOL Tax Effected NOL Expiration Years Colombia $ 64 $ 22 2019 Mexico 8,482 2,545 2020-2024 Norway 249 67 Indefinite Singapore 131 22 Indefinite Sweden 513 113 Indefinite Switzerland 11,371 1,028 2016-2020 Taiwan 7,133 1,213 2016-2024 Ukraine (1) 581 105 Indefinite United States (states) 11,079 277 2016-2032 (1)
Summary of valuation allowance	The valuation allowances presented below (in millions) “more likely than not Country 2015 2014 Mexico $ 2.5 $ 2.7 Norway — 0.1 Sweden 0.1 0.1 Switzerland 1.0 1.2 Taiwan 1.2 1.2 Ukraine (1) 0.1 0.1 United States 4.0 4.3 Other Jurisdictions 0.1 — Total $ 9.0 $ 9.7 (1)
Deferred tax assets (liabilities) classified in Consolidated Balance Sheets	Deferred tax assets (liabilities) are classified in the accompanying Consolidated Balance Sheets of December 31 as follows (in thousands) 2015 2014 Current deferred tax assets $ 460 $ 1,141 Noncurrent deferred tax assets 3,725 3,320 Current deferred tax liabilities (84 ) (123 ) Other long-term liabilities (24 ) (26 ) Net deferred tax assets $ 4,077 $ 4,312
Unrecognized tax benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows, for the years ended December 31, 2015 and 2014 (in thousands): 2015 2014 Balance as of January 1 $ 803 $ 738 Additions for tax positions related to the current year — 1 Additions for tax positions of prior years — 111 Reductions of tax positions of prior years (71 ) (47 ) Settlements (17 ) — Balance as of December 31 $ 715 $ 803
Tax years subject to examinations	As of December 31, 2015, the tax years that remained subject to examination by a major tax jurisdiction for the Company’s most significant subsidiaries were as follows: Jurisdiction Open Years Australia 2011-2015 Canada 2011-2015 Denmark 2012-2015 Japan 2012-2015 Mexico 2011-2015 Norway 2009-2015 Republic of Korea 2010-2015 Singapore 2011-2015 South Africa 2012-2015 Sweden 2010-2015 Switzerland 2010-2015 Taiwan 2010-2015 United Kingdom 2009-2015 United States 2012-2015

TRANSACTIONS WITH RELATED PAR35

TRANSACTIONS WITH RELATED PARTIES AND AFFILIATES (Tables)	12 Months Ended
	Dec. 31, 2015
TRANSACTIONS WITH RELATED PARTIES AND AFFILIATES [Abstract]
Related party transactions	The Company made cash donations and sold products to MannaRelief as follows: 2015 2014 Sold Products $ — million $ 0.3 million Contributed Cash Donations $ — million $ 0.3 million

EMPLOYEE BENEFIT PLANS (Tables)

EMPLOYEE BENEFIT PLANS (Tables)	12 Months Ended
	Dec. 31, 2015
EMPLOYEE BENEFIT PLANS [Abstract]
Benefit Plan's projected benefit obligation and valuation of plan assets	The Benefit Plan’s projected benefit obligation and valuation of plan assets were as follows for the years ended December 31 (in thousands) Projected benefit obligation: 2015 2014 Balance, beginning of year $ 549 $ 629 Service cost 75 88 Interest cost 3 3 Liability losses (4 ) (6 ) Benefits paid to participants (141 ) (122 ) Special termination benefit — 34 Foreign currency (3 ) (77 ) Balance, end of year $ 479 $ 549 Plan assets: 2015 2014 Fair value, beginning of year $ — $ — Company contributions 141 122 Benefits paid to participants (141 ) (122 ) Fair value, end of year $ — $ — Funded status of the Benefit Plan as of December 31 (in thousands) 2015 2014 Benefit obligation $ (479 ) $ (549 ) Fair value of plan assets — — Excess of benefit obligation over fair value of plan assets $ (479 ) $ (549 ) Amounts recognized in the accompanying Consolidated Balance Sheets consist of, as of December 31 (in thousands) 2015 2014 Accrued benefit liability $ (479 ) $ (549 ) Transition obligation and unrealized gain (339 ) (372 ) Net amount recognized in the consolidated balance sheets $ (818 ) $ (921 ) Years Ended December 31, Other changes recognized in comprehensive income (loss) (in thousands): 2015 2014 Net periodic cost $ 43 $ 85 Current year gain (4 ) (6 ) Amortization of transition obligation (4 ) (4 ) Total recognized in other comprehensive income (loss) (8 ) (10 ) Total recognized in comprehensive income (loss) $ 35 $ 75 As of December 31, Amounts not yet reflected in net periodic benefit cost and included in accumulated other comprehensive gain (loss) (in thousands) 2015 2014 Transition obligation $ 22 $ 13 Prior service cost 313 353 Net actuarial gain 4 6 Total recognized in accumulated other comprehensive gain (loss) $ 339 $ 372 2016 estimated amounts of amortized transition obligation (in thousands): 2016 Transition obligation $ (4 ) As of December 31, Aggregate Benefit Plan information and accumulated benefit obligation in excess of plan assets (in thousands): 2015 2014 Projected benefit obligation $ 479 $ 549 Accumulated benefit obligation 479 549 Fair value of plan assets — —
Weighted-average assumptions to determine the benefit obligation and net cost	The weighted-average assumptions to determine the benefit obligation and net cost are as follows: 2015 2014 Discount rate 0.40 % 0.50 % Rate of increase in compensation levels — % — %
Pension expense for Benefit Plan included in selling, general and administrative expenses	Pension expense for the Benefit Plan is included in selling, general and administrative expenses in the Consolidated Statements of Operations and is comprised of the following for the years ended December 31 (in thousands) 2015 2014 Service cost $ 75 $ 88 Interest cost 3 3 Amortization of transition obligation 4 4 Gain — — Special termination — 34 Prior service cost (39 ) (44 ) Benefit adjustment — — Total pension expense $ 43 $ 85
Benefits expected to be paid by the Benefit Plan	As of December 31, 2015, benefits expected to be paid by the Benefit Plan for the next ten years is approximately as follows (in thousands) 2016 $ 53 2017 52 2018 49 2019 49 2020 43 Next five years 368 Total expected benefits to be paid $ 614

STOCK OPTION PLAN (Tables)

STOCK OPTION PLAN (Tables)	12 Months Ended
	Dec. 31, 2015
STOCK OPTION PLAN [Abstract]
Changes in stock options outstanding	A summary of changes in stock options outstanding during the year ended December 31, 2015, is as follows: 2015 Numberof Options (in thousands) Weighted average exercise price Weighted average remaining contractual life (in years) Aggregate intrinsic value (in thousands) Outstanding at beginning of year 249 16.71 Granted 37 19.18 Exercised (5 ) 5.72 Forfeited or expired (55 ) 19.78 Outstanding at end of year 226 16.61 7.09 505 Options exercisable at year end 148 16.95 6.34 282
Assumptions used to calculate compensation expense and fair value of stock options granted	The following assumptions were used to calculate the compensation expense and the calculated fair value of stock options granted each year: 2015 2014 Dividend yield: — (1) — (1) Risk-free interest rate: 1.2 – 1.6 % 1.3 - % Expected market price volatility: 79.1 – 80.1 % 77.1 – % Average expected life of stock options: 4.5 years 4.5 years (1)
Share-based compensation expense	The Company recorded the following amounts related to the expense of the fair values of options during the years ended December 31, 2015 and 2014 (in thousands) 2015 2014 Selling, general and administrative expenses and income from operations before income taxes $ 575 $ 512 Benefit for income taxes (137 ) (137 ) Effect on net income $ 438 $ 375
Unrecognized compensation cost	As of December 31, 2015, the Company had approximately $0.6 million of total unrecognized compensation expense related to stock options currently outstanding, to be recognized in future years, ending December 31, as follows (in thousands): Total gross unrecognized compensation expense Total tax benefit associated with unrecognized compensation expense Total net unrecognized compensation expense 2016 $ 352 $ 54 $ 298 2017 176 18 158 2018 99 — 99 $ 627 $ 72 $ 555

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2015
COMMITMENTS AND CONTINGENCIES [Abstract]
Future minimum rental commitments for non-cancelable operating leases	Approximate future minimum rental commitments for non-cancelable operating leases (in thousands) Years ending December 31, 2016 $ 1,729 2017 1,430 2018 787 2019 297 2020 112 Thereafter — $ 4,355

SHAREHOLDERS' EQUITY (Tables)

SHAREHOLDERS' EQUITY (Tables)	12 Months Ended
	Dec. 31, 2015
SHAREHOLDERS' EQUITY [Abstract]
Components of accumulated other comprehensive income (loss)	The after-tax components of accumulated other comprehensive income (loss), are as follows (in thousands) Foreign Currency Translation Pension Postretirement Benefit Obligation Accumulated Other Comprehensive Loss, Net Balance as of December 31, 2014 $ (457 ) $ 348 $ (109 ) Current-period change before reclassifications 815 — 815 Amounts reclassified from accumulated other comprehensive income (loss) — (31 ) (31 ) Income tax provision — 11 11 Balance as of December 31, 2015 $ 358 $ 328 $ 686

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2015
SEGMENT INFORMATION [Abstract]
Net sales shipped to customers by geographic region	Consolidated net sales shipped to customers in these regions, along with pack and product information for the years ended December 31, are as follows (in millions, except percentages) Region 2015 2014 North America $ 73.3 40.7 % $ 80.8 42.5 % Asia/Pacific 91.4 50.7 % 92.4 48.6 % EMEA 15.6 8.6 % 16.9 8.9 % Total $ 180.3 100.0 % $ 190.1 100.0 %
Product and pack information	2015 2014 Consolidated product sales $ 143.1 $ 155.3 Consolidated pack sales 31.7 27.8 Consolidated other, including freight 5.5 7.0 Total $ 180.3 $ 190.1
Long-lived assets, by geographic region	Long-lived assets by region, which include property and equipment and construction in progress for the Company and its subsidiaries, as of December 31, reside in the following regions, as follows (in millions) Region 2015 2014 North America $ 3.5 $ 3.1 Asia/Pacific 1.1 0.8 EMEA 0.1 0.2 Total $ 4.7 $ 4.1
Inventory balances, by country	Inventory balances by region, which consist of raw materials, and finished goods, including promotional materials, and offset by obsolete inventories, for the Company and its subsidiaries, reside in the following regions as of December 31, as follows (in millions) Region 2015 2014 North America $ 3.4 $ 4.0 Asia/Pacific 4.3 4.3 EMEA 1.5 2.3 Total $ 9.2 $ 10.6

ORGANIZATION AND SUMMARY OF S41

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) $ in Thousands		12 Months Ended
		Dec. 31, 2015USD ($)RegionPeriodPlanProductLine	Dec. 31, 2014USD ($)
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Number of regions in which company sells products | Region		3
Foreign Currency Translation [Abstract]
Transaction gains (losses)		$ (4,200)	$ (3,000)
Cash and Cash Equivalents [Abstract]
Credit card receivables		400	1,200
Cash and cash equivalents held in foreign bank accounts		31,300	24,800
Restricted Cash [Abstract]
Restricted cash		8,100	8,600
Accounts Receivables [Abstract]
Allowance for doubtful accounts		300	200
Other Assets [Abstract]
Other assets		3,759	3,567
Deposits for building leases		1,900	1,500
Fair trade commission deposits		1,600	1,700
Indefinite lived intangible assets		200	200
Notes Payable [Abstract]
Notes payable		1,800
Notes payable, current portion		713	0
Notes payable, long-term portion		1,069	0
Other Long-Term Liabilities [Abstract]
Other long-term liabilities		1,994	2,136
Uncertain income tax positions recorded in noncurrent liabilities		700	800
Accrued lease restoration costs		400	400
Defined benefit plan obligation		(479)	(549)
Revenue Recognition [Abstract]
Deferred revenue		8,700	10,900
Deferred commissions		3,443	4,544
Loyalty Program [Abstract]
Loyalty deferred revenue, beginning balance		9,703	5,456
Loyalty points forfeited		(8,801)	(4,664)
Loyalty points used		(15,077)	(12,348)
Loyalty points vested		20,403	19,580
Loyalty points unvested		1,845	1,679
Loyalty deferred revenue, ending balance		$ 8,073	9,703
Percentage of sale returns		1.50%
Commissions and Incentives Expenses [Abstract]
Number of business periods per year | Period		13
Number of days per business period		28 days
Number of weeks following business period end for payment of product sales commissions		three weeks
Number of weeks following business period end for payment of pack sales commissions		five weeks
Advertising Expenses [Abstract]
Advertising and promotional expense		$ 5,500	4,900
Research and Development Expenses [Abstract]
Research and development consulting fees		$ 1,700	1,600
Stock-Based Compensation [Abstract]
Number of active stock based compensation plan | Plan		1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentages of stock option ownership considered for higher exercise price of option		10.00%
Option exercise price as percentages of closing exercise price of stock for specific shareholders		110.00%
Concentration Risk [Line Items]
Number of products | ProductLine		5
Concentration risk, sales by product		$ 90,886	$ 107,571
Concentration risk, percentage of net sales		50.40%	56.60%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of stock options		2 years
Percentages of stock option ownership considered for higher exercise price of option		10.00%
Expiration period of stock option plan		5 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of stock options		3 years
Option exercise price as percentages of closing exercise price of stock for specific shareholders		110.00%
Expiration period of stock option plan		10 years
Reserve for Sales Returns [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of year		$ 207	$ 238
Provision related to sales made in current period		1,456
Adjustment related to sales made in prior periods		(10)
Actual returns or credits related to current period		(1,319)
Actual returns or credits related to prior periods		(187)
Balance at end of year		$ 147	207
Office Furniture and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		5 years
Office Furniture and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		7 years
Computer Hardware and Software [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		3 years
Computer Hardware and Software [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		5 years
Automobiles [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		3 years
Automobiles [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		5 years
Leasehold Improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	[1]	2 years
Leasehold Improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	[1]	10 years
Software [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of software		3 years
Software [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of software		5 years
Advanced Ambrotose [Member]
Concentration Risk [Line Items]
Concentration risk, sales by product		$ 59,026	$ 63,791
Concentration risk, percentage of net sales		32.70%	33.60%
Ambrotose [Member]
Concentration Risk [Line Items]
Concentration risk, sales by product		$ 9,686	$ 10,895
Concentration risk, percentage of net sales		5.40%	5.70%
NutriVerus [Member]
Concentration Risk [Line Items]
Concentration risk, sales by product		$ 8,541	$ 10,530
Concentration risk, percentage of net sales		4.70%	5.50%
PLUS [Member]
Concentration Risk [Line Items]
Concentration risk, sales by product		$ 8,239	$ 8,923
Concentration risk, percentage of net sales		4.60%	4.70%
Uth Skin Rejuvenation [Member]
Concentration Risk [Line Items]
Concentration risk, sales by product		$ 5,394	$ 13,431
Concentration risk, percentage of net sales		3.00%	7.10%
[1]	The Company amortizes leasehold improvements over the shorter of the useful estimated life of the leased asset or the lease term.

FAIR VALUE (Details)

FAIR VALUE (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restricted cash	$ 8,100	$ 8,600
Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money Market Funds - Fidelity, US	319	392
Interest bearing deposits - various banks	14,134	12,322
Cash and cash equivalents	8,281	6,159
Restricted cash	737	738
Long-term restricted cash	5,435	5,817
Total	14,453	12,714
Recurring Basis [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money Market Funds - Fidelity, US	319	392
Interest bearing deposits - various banks	14,134	12,322
Cash and cash equivalents	8,281	6,159
Restricted cash	737	738
Long-term restricted cash	5,435	5,817
Total	14,453	12,714
Recurring Basis [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money Market Funds - Fidelity, US	0	0
Interest bearing deposits - various banks	0	0
Cash and cash equivalents	0	0
Restricted cash	0	0
Long-term restricted cash	0	0
Total	0	0
Recurring Basis [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money Market Funds - Fidelity, US	0	0
Interest bearing deposits - various banks	0	0
Cash and cash equivalents	0	0
Restricted cash	0	0
Long-term restricted cash	0	0
Total	$ 0	$ 0

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
INVENTORIES [Abstract]
Raw materials	$ 1,187	$ 2,118
Finished goods	9,277	10,615
Inventory reserves for obsolescence	(1,265)	(2,142)
Total	$ 9,199	$ 10,591

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Summary of property and equipment [Abstract]
Property and equipment, gross	$ 76,521	$ 75,546
Less accumulated depreciation and amortization	(72,673)	(73,065)
Property and equipment, net	3,848	2,481
Construction in progress	839	1,622
Total	4,687	4,103
Office Furniture and Equipment [Member]
Summary of property and equipment [Abstract]
Property and equipment, gross	8,576	8,666
Computer Hardware [Member]
Summary of property and equipment [Abstract]
Property and equipment, gross	7,747	7,738
Computer Software [Member]
Summary of property and equipment [Abstract]
Property and equipment, gross	47,724	46,791
Automobiles [Member]
Summary of property and equipment [Abstract]
Property and equipment, gross	81	81
Leasehold Improvements [Member]
Summary of property and equipment [Abstract]
Property and equipment, gross	12,393	12,270
Construction in Process [Member]
Summary of property and equipment [Abstract]
Construction in progress	$ 839	$ 1,622

CAPITAL LEASE OBLIGATIONS (Deta

CAPITAL LEASE OBLIGATIONS (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
CAPITAL LEASE OBLIGATIONS [Abstract]
Net book value of leased assets	$ 1,100	$ 1,300
Schedule of future minimum lease payments [Abstract]
2,016	492
2,017	370
2,018	205
2,019	52
2,020	13
Total future minimum lease payments	1,132
Less: Amounts representing interest (effective interest rate 4.74%)	(73)
Present value of minimum lease payments	1,059
Current portion of capital lease obligations	447	901
Long-term portion of capital lease obligations	$ 612	$ 852
Capital Lease [Member]
Capital Leased Assets [Line Items]
Effective interest rate	4.74%

ACCRUED EXPENSES (Details)

ACCRUED EXPENSES (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Summary of accrued expenses [Abstract]
Accrued asset purchases	$ 277	$ 291
Accrued compensation	1,620	2,180
Accrued royalties	68	105
Accrued sales and other taxes	2,323	1,193
Other accrued operating expenses	562	786
Customer deposits and sales returns	153	211
Accrued travel expenses related to corporate events	271	107
Accrued shipping and handling costs	257	344
Rent expense	76	147
Accrued legal and accounting fees	614	992
Total	$ 6,221	$ 6,356

INCOME TAXES, INCOME BEFORE INC

INCOME TAXES, INCOME BEFORE INCOME TAXES AND INCOME TAX PROVISION (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Components of Company's loss before income taxes [Abstract]
United States	$ 769	$ 2,044
Foreign	7,430	7,777
Income before income taxes	8,199	9,821
Current provision (benefit) [Abstract]
Federal	(336)	2,433
State	21	43
Foreign	2,518	2,547
Total	2,203	5,023
Deferred provision (benefit) [Abstract]
Federal	191	(1,792)
State	72	349
Foreign	(106)	(255)
Total	157	(1,698)
Total	$ 2,360	$ 3,325

INCOME TAXES, RECONCILIATION OF

INCOME TAXES, RECONCILIATION OF STATUTORY TO EFFECTIVE TAX RATE (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Reconciliation of effective income tax rate and United States federal statutory income tax rate [Abstract]
Federal statutory income taxes	35.00%	35.00%
State income taxes, net of federal benefit	1.00%	3.50%
Difference in foreign and United States tax on foreign operations	(14.80%)	(16.10%)
Effect of changes in valuation allowance for net operating loss carryforwards	(8.70%)	14.30%
Effect of change in uncertain tax positions (net)	(0.20%)	0.50%
Federal Sub-Part F Income from foreign operations	5.10%	2.90%
Foreign exchange	5.30%	(0.30%)
Other	6.20%	(5.90%)
Total	28.90%	33.90%

INCOME TAXES, DEFERRED TAX ASSE

INCOME TAXES, DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014
Current [Abstract]
Deferred revenue		$ 567,000	$ 453,000
Inventory capitalization		209,000	171,000
Inventory reserves		376,000	762,000
Accrued expenses		974,000	697,000
Other		205,000	127,000
Total current deferred tax assets		2,331,000	2,210,000
Noncurrent [Abstract]
Depreciation and amortization		1,788,000	1,867,000
Net operating loss	[1]	5,378,000	5,842,000
Deferred revenue		16,000	28,000
Non-cash accounting charges related to stock options and warrants		684,000	628,000
Accrued expenses		239,000	350,000
Foreign tax credit carryover		3,568,000	3,855,000
Other		620,000	506,000
Total noncurrent deferred tax assets		12,293,000	13,076,000
Total deferred tax assets		14,624,000	15,286,000
Valuation allowance		(9,028,000)	(9,745,000)
Total deferred tax assets, net of valuation allowance		5,596,000	5,541,000
Current [Abstract]
Prepaid expenses		406,000	413,000
Deferred commissions		846,000	769,000
Other			10,000
Total current deferred tax liabilities		1,252,000	1,192,000
Noncurrent [Abstract]
Internally-developed software		266,000	11,000
Depreciation and amortization		1,000	2,000
Sub-Part F income deferred		0	0
Other		0	24,000
Total noncurrent deferred tax liabilities		267,000	37,000
Total deferred tax liabilities		1,519,000	1,229,000
Operating Loss Carryforwards [Line Items]
Foreign tax credit carryforward		3,100
Charitable contribution carryforward		500
Colombia [Member]
Operating Loss Carryforwards [Line Items]
Gross NOL		64,000
Tax Effected NOL		$ 22,000
Expiration Years		2,019
Mexico [Member]
Noncurrent [Abstract]
Valuation allowance		$ (2,500,000)	(2,700,000)
Operating Loss Carryforwards [Line Items]
Gross NOL		8,482,000
Tax Effected NOL		$ 2,545,000
Expiration Years		2020-2024
Norway [Member]
Noncurrent [Abstract]
Valuation allowance		$ 0	(100,000)
Operating Loss Carryforwards [Line Items]
Gross NOL		249,000
Tax Effected NOL		$ 67,000
Expiration Years		Indefinite
Singapore [Member]
Operating Loss Carryforwards [Line Items]
Gross NOL		$ 131,000
Tax Effected NOL		$ 22,000
Expiration Years		Indefinite
Sweden [Member]
Noncurrent [Abstract]
Valuation allowance		$ (100,000)	(100,000)
Operating Loss Carryforwards [Line Items]
Gross NOL		513,000
Tax Effected NOL		$ 113,000
Expiration Years		Indefinite
Switzerland [Member]
Noncurrent [Abstract]
Valuation allowance		$ (1,000,000)	(1,200,000)
Operating Loss Carryforwards [Line Items]
Gross NOL		11,371,000
Tax Effected NOL		$ 1,028,000
Expiration Years		2016-2020
Taiwan [Member]
Noncurrent [Abstract]
Valuation allowance		$ (1,200,000)	(1,200,000)
Operating Loss Carryforwards [Line Items]
Gross NOL		7,133,000
Tax Effected NOL		$ 1,213,000
Expiration Years		2016-2024
Ukraine [Member]
Noncurrent [Abstract]
Valuation allowance	[2]	$ (100,000)	(100,000)
Operating Loss Carryforwards [Line Items]
Gross NOL	[2]	581,000
Tax Effected NOL	[2]	$ 105,000
Expiration Years	[2]	Indefinite
United States (states) [Member]
Operating Loss Carryforwards [Line Items]
Gross NOL		$ 11,079,000
Tax Effected NOL		$ 277,000
Expiration Years		2016-2032
United States [Member]
Noncurrent [Abstract]
Valuation allowance		$ (4,000,000)	$ (4,300,000)
[1]	(1) The Company's net operating loss will expire as follows (dollar amounts in thousands): Jurisdiction Gross NOL Tax Effected NOL Expiration Years Colombia $ 64 22 2019 Mexico 8,482 2,545 2020-2024 Norway 249 67 Indefinite Singapore 131 22 Indefinite Sweden 513 113 Indefinite Switzerland 11,371 1,028 2016-2020 Taiwan 7,133 1,213 2016-2024 Ukraine 581 105 Indefinite United States (states) - 277 2016-2032
[2]	On March 21, 2014, the Company suspended operations in the Ukraine.

INCOME TAXES, VALUATION ALLOWAN

INCOME TAXES, VALUATION ALLOWANCE (Details) - USD ($) $ in Thousands		Dec. 31, 2015	Dec. 31, 2014
Valuation Allowance [Line Items]
Valuation allowance		$ 9,028	$ 9,745
Mexico [Member]
Valuation Allowance [Line Items]
Valuation allowance		2,500	2,700
Norway [Member]
Valuation Allowance [Line Items]
Valuation allowance		0	100
Sweden [Member]
Valuation Allowance [Line Items]
Valuation allowance		100	100
Switzerland [Member]
Valuation Allowance [Line Items]
Valuation allowance		1,000	1,200
Taiwan [Member]
Valuation Allowance [Line Items]
Valuation allowance		1,200	1,200
United States [Member]
Valuation Allowance [Line Items]
Valuation allowance		4,000	4,300
Ukraine [Member]
Valuation Allowance [Line Items]
Valuation allowance	[1]	100	100
Other Jurisdiction [Member]
Valuation Allowance [Line Items]
Valuation allowance		$ 100	$ 0
[1]	On March 21, 2014, the Company suspended operations in the Ukraine.

INCOME TAXES, DEFERRED TAX AS51

INCOME TAXES, DEFERRED TAX ASSETS (LIABILITIES) CLASSIFIED IN CONSOLIDATED BALANCE SHEETS (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Deferred tax assets liabilities classified in Consolidated Balance Sheets [Abstract]
Current deferred tax assets	$ 460	$ 1,141
Noncurrent deferred tax assets	3,725	3,320
Current deferred tax liabilities	(84)	(123)
Other long-term liabilities	(24)	(26)
Net deferred tax assets	$ 4,077	$ 4,312

INCOME TAXES, UNRECOGNIZED TAX

INCOME TAXES, UNRECOGNIZED TAX BENEFITS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
INCOME TAXES [Abstract]
Uncertain income tax positions recorded in current liabilities	$ 100
Uncertain income tax positions recorded in noncurrent liabilities	700	$ 800
Unrecognized tax benefits that would impact effective tax rate	600
Reconciliation of beginning and ending amount of unrecognized tax benefits [Roll Forward]
Balance as of January 1	803	738
Additions for tax positions related to the current year	0	1
Additions for tax positions of prior years	0	111
Reductions of tax positions of prior years	(71)	(47)
Settlements	(17)	0
Balance as of December 31	715	803
Accrued Penalties and Interest [Abstract]
Accrued interest and penalties in the consolidated balance sheets	200	100
Accrued interest and penalties in the consolidated statement of operations	26	$ 56
Decrease in unrecognized tax benefits due to the lapse of statutes of limitations	$ 100

INCOME TAXES, TAX YEARS SUBJECT

INCOME TAXES, TAX YEARS SUBJECT TO EXAMINATIONS (Details)	12 Months Ended
	Dec. 31, 2015
Australia [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,011
Australia [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
Canada [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,011
Canada [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
Denmark [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,012
Denmark [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
Japan [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,012
Japan [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
Mexico [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,011
Mexico [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
Norway [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,009
Norway [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
Republic of Korea [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,010
Republic of Korea [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
Singapore [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,011
Singapore [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
South Africa [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,012
South Africa [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
Sweden [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,010
Sweden [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
Switzerland [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,010
Switzerland [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
Taiwan [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,010
Taiwan [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
United Kingdom [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,009
United Kingdom [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015
United States [Member] | Earliest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,012
United States [Member] | Latest Open Tax Year [Member]
Income Tax Examination [Line Items]
Open tax years	2,015

TRANSACTIONS WITH RELATED PAR54

TRANSACTIONS WITH RELATED PARTIES AND AFFILIATES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Directors, Officers and Family Members on M5M Foundation Board [Member]
Cash donations and sold products [Abstract]
Cash donations	$ 900,000	$ 500,000
Son of the Chairman of the Board [Member]
Related Party Transaction [Line Items]
Officers' compensation	251,000
Member of the Board of Directors and Family [Member]
Cash donations and sold products [Abstract]
Payment of employment related compensation	3,200,000	2,900,000
Member of the Board of Directors [Member]
Cash donations and sold products [Abstract]
Payment of employment related compensation	2,900,000	2,600,000
Family members of a Member of the Board of Directors [Member]
Cash donations and sold products [Abstract]
Payment of employment related compensation	300,000	300,000
Son of member of Board of Directors [Member]
Cash donations and sold products [Abstract]
Payment of employment related compensation	200,000	200,000
Daughter and Daughter-in-law of Member of Board of Directors [Member]
Cash donations and sold products [Abstract]
Payment of employment related compensation	100,000	100,000
Second son of member of Board of Directors [Member]
Cash donations and sold products [Abstract]
Payment of employment related compensation	100,000
Spouse of President [Member]
Cash donations and sold products [Abstract]
Payment of employment related compensation	$ 200,000	200,000
Founder and Former Chairman of the Board [Member]
Related Party Transaction [Line Items]
Beneficial ownership	5.00%		18.00%
Cash donations and sold products [Abstract]
Consulting services charged		100,000
MannaRelief [Member]
Cash donations and sold products [Abstract]
Sold Products	$ 0	300,000
Cash donations	$ 0	$ 300,000

EMPLOYEE BENEFIT PLANS (Details

EMPLOYEE BENEFIT PLANS (Details)	12 Months Ended
	Dec. 31, 2015USD ($)Age	Dec. 31, 2014USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
EMPLOYEE BENEFIT PLANS [Abstract]
Service period, minimum	3 months
Employees eligible age under plan, minimum | Age	21
Maximum annual contribution per employee	100.00%
Vesting period of employer's matching contributions	5 years
Contributions by employer	$ 200,000	$ 200,000
Projected benefit obligation [Roll Forward]
Balance, beginning of year	549,000	629,000
Service cost	75,000	88,000
Interest cost	3,000	3,000
Liability losses	(4,000)	(6,000)
Benefits paid to participants	(141,000)	(122,000)
Special termination benefit	0	34,000
Foreign currency	(3,000)	(77,000)
Balance, end of year	479,000	549,000
Plan assets [Roll Forward]
Fair value, beginning of year	0	0
Company contributions	141,000	122,000
Benefits paid to participants	(141,000)	(122,000)
Fair value, end of year	0	0
Funded status of the Benefit Plan [Abstract]
Benefit obligation	(549,000)	(549,000)	$ (479,000)	$ (549,000)
Fair value of plan assets	0	0	0	0
Excess of benefit obligation over fair value of plan assets			(479,000)	(549,000)
Amounts recognized in the accompanying Consolidated Balance Sheets [Abstract]
Accrued benefit liability			(479,000)	(549,000)
Transition obligation and unrealized gain			(339,000)	(372,000)
Net amount recognized in the consolidated balance sheets			(818,000)	(921,000)
Other changes recognized in comprehensive income (loss) [Abstract]
Net periodic cost	43,000	85,000
Current year gain	(4,000)	(6,000)
Amortization of transition obligation	(4,000)	(4,000)
Total recognized in other comprehensive income (loss)	(8,000)	(10,000)
Total recognized in comprehensive income (loss)	35,000	75,000
Amounts not yet reflected in net periodic benefit cost and included in accumulated other comprehensive gain (loss) [Abstract]
Transition obligation			22,000	13,000
Prior service cost			313,000	353,000
Net actuarial gain			4,000	6,000
Total recognized in accumulated other comprehensive gain (loss)			339,000	372,000
2016 estimated amounts of amortized transition obligation [Abstract]
Transition obligation	(4,000)
Aggregate Benefit Plan information and accumulated benefit obligation in excess of plan assets [Abstract]
Projected benefit obligation			479,000	549,000
Accumulated benefit obligation			479,000	549,000
Fair value of plan assets			$ 0	$ 0
Weighted-average assumptions to determine the benefit obligation and net cost [Abstract]
Discount rate			0.40%	0.50%
Rate of increase in compensation levels			0.00%	0.00%
Pension expense for Benefit Plan included in selling, general and administrative expenses [Abstract]
Service cost	75,000	88,000
Interest cost	3,000	3,000
Amortization of transition obligation	4,000	4,000
Gain	0	0
Special termination	0	34,000
Prior service cost	(39,000)	(44,000)
Benefit adjustment	0	0
Total pension expense	43,000	$ 85,000
Expected employer's contributions in 2016	$ 53,000
Period over which benefits are expected to be paid	10 years
Benefits expected to be paid by the Benefit Plan [Abstract]
2,016			$ 53,000
2,017			52,000
2,018			49,000
2,019			49,000
2,020			43,000
Next five years			368,000
Total expected benefits to be paid			$ 614,000

STOCK OPTION PLAN (Details)

STOCK OPTION PLAN (Details) $ / shares in Units, $ in Thousands		May. 28, 2014shares	Dec. 31, 2015USD ($)Plan$ / sharesshares	Dec. 31, 2014USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of active stock based compensation plan | Plan			1
Percentage of stock option ownership considered for higher exercise price of option			10.00%
Option exercise price as percentages of closing exercise price of stock for specific shareholders			110.00%
Number of shares authorized (in shares) | shares			100,000
Number of shares adjusted due to reverse stock split (in shares) | shares			10
Increase in number of shares authorized (in shares) | shares		130,000	100,000
Number of shares available for grant (in shares) | shares			127,124
Non-vested shares (in shares) | shares			77,000	121,000
New shares issued (in shares) | shares			5,001
Number of Options [Roll Forward]
Outstanding at beginning of year (in shares) | shares			249,000
Granted (in shares) | shares			37,000
Exercised (in shares) | shares			(5,000)
Forfeited or expired (in shares) | shares			(55,000)
Outstanding at end of year (in shares) | shares			226,000	249,000
Options exercisable at year end (in shares) | shares			148,000
Weighted average exercise price [Roll Forward]
Outstanding at beginning of year (in dollars per share) | $ / shares			$ 16.71
Granted (in dollars per share) | $ / shares			19.18
Exercised (in dollars per share) | $ / shares			5.72
Forfeited or expired (in dollars per share) | $ / shares			19.78
Outstanding at end of year (in dollars per share) | $ / shares			16.61	$ 16.71
Options exercisable at year end (in dollars per share) | $ / shares			$ 16.95
Weighted average remaining contractual life (in years) [Abstract]
Outstanding at end of year			7 years 1 month 2 days
Options exercisable at year end			6 years 4 months 2 days
Aggregate intrinsic value [Abstract]
Outstanding at end of year			$ 505
Options exercisable at year end			$ 282
Assumptions used to calculate compensation expense and fair value of stock options granted [Abstract]
Dividend yield	[1]		0.00%	0.00%
Risk-free interest rate, minimum			1.20%	1.30%
Risk-free interest rate, maximum			1.60%	1.50%
Expected market price volatility, minimum			79.10%	77.10%
Expected market price volatility, maximum			80.10%	80.50%
Average expected life of stock options			4 years 6 months	4 years 6 months
Dividends declared			$ 0	$ 0
Weighted-average grant-date fair value (in dollars per share) | $ / shares			$ 11.90	$ 11.25
Total fair value of shares vested			$ 600	$ 100
Summary of amounts related to the expense of the fair values of options [Abstract]
Selling, general and administrative expenses and income from operations before income taxes			575	512
Benefit for income taxes			(137)	(137)
Effect on net income			438	375
Unrecognized compensation expense [Abstract]
Total gross unrecognized compensation expense in 2016			352
Total gross unrecognized compensation expense in 2017			176
Total gross unrecognized compensation expense in 2018			99
Total unrecognized compensation expense			627
Tax benefit associated with unrecognized compensation expense in 2016			54
Tax benefit associated with unrecognized compensation expense in 2017			18
Tax benefit associated with unrecognized compensation expense in 2018			0
Total tax benefit associated with unrecognized compensation expense			72
Total net unrecognized compensation expense in 2016			298
Total net unrecognized compensation expense in 2017			158
Total net unrecognized compensation expense in 2018			99
Total net unrecognized compensation expense			$ 555
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of stock options			2 years
Percentage of stock option ownership considered for higher exercise price of option			10.00%
Expiration period of stock option plan			5 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of stock options			3 years
Option exercise price as percentages of closing exercise price of stock for specific shareholders			110.00%
Expiration period of stock option plan			10 years
Intrinsic value of exercised options			$ 100	$ 200
Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares) | shares			1,000
[1]	The Company declared no dividends in 2015 or 2014.

COMMITMENTS AND CONTINGENCIES57

COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
COMMITMENTS AND CONTINGENCIES [Abstract]
Lease expiration date	Aug. 31, 2023
Total rent expense	$ 3,600	$ 3,900
Summary of future minimum rental commitments for non-cancelable operating leases [Abstract]
2,016	1,729
2,017	1,430
2,018	787
2,019	297
2,020	112
Thereafter	0
Total	4,355
Royalty and Consulting Agreements [Abstract]
Payment of royalties	200	$ 300
Payable amount on termination of employment relationships with executives	$ 1,500
Purchase Commitments Agreement with InB:Biotechnologies, Inc. [Member]
Purchase Commitment, Excluding Long-term Commitment [Line Items]
Supply agreement period	10 years
Purchase commitment aggregate amount	$ 5,000

LITIGATION (Details)

LITIGATION (Details) - USD ($)	Feb. 18, 2015	Dec. 31, 2015	May. 29, 2015
Samuel L. Caster and Wonder Enterprises, LLC [Member]
Loss Contingencies [Line Items]
Minimum estimated damages			$ 500,000
Maximum estimated damages			$ 3,500,000
Pending Litigation [Member] | Ms. Diana Anselmo and New Day Today Corporation [Member]
Loss Contingencies [Line Items]
Damages sought	$ 1,000,000
Pending Litigation [Member] | Busan Custom Office [Member]
Loss Contingencies [Line Items]
Damages paid		$ 1,000,000

SHAREHOLDERS' EQUITY (Details)

SHAREHOLDERS' EQUITY (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Mar. 10, 2016	Aug. 28, 2006	Jun. 30, 2004	May. 19, 1998
Preferred Stock [Abstract]
Common stock, shares authorized (in shares)	99,000,000	99,000,000				100,000,000
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Equity, Class of Treasury Stock [Line Items]
Shares issued as compensation for the work (in shares)	1,000
Shares issued due to exercise of stock options (in shares)	5,001
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ (109)
Current-period change before reclassifications	815
Amounts reclassified from accumulated other comprehensive income (loss)	(31)
Income tax provision	11	$ 11
Ending balance	$ 686	(109)
June 2004 Plan [Member]
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, repurchase authorization	the lesser of (i) 131,756 shares of its common stock and (ii) $1.3 million of its shares
Number of common shares authorized to be repurchased (in shares)					131,756
Stock repurchase program, authorized amount					$ 1,300
June 2004 Plan [Member] | Subsequent Event [Member]
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, remaining number of shares authorized to be repurchased (in shares)			19,084
Stock repurchased since inception shares (in shares)			112,672
August 2006 Plan [Member]
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, repurchase authorization	up to $20 million of its outstanding shares
Stock repurchase program, authorized amount				$ 20,000
Common stock repurchased (in shares)	0
Foreign Currency Translation [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ (457)
Current-period change before reclassifications	815
Amounts reclassified from accumulated other comprehensive income (loss)	0
Income tax provision	0
Ending balance	358	(457)
Pension Postretirement Benefit Obligation [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	348
Current-period change before reclassifications	0
Amounts reclassified from accumulated other comprehensive income (loss)	(31)
Income tax provision	11
Ending balance	$ 328	$ 348

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - $ / shares shares in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Average common stock close price (in dollars per share)	$ 20.17	$ 16.66
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0.1	0.1

SEGMENT INFORMATION (Details)

SEGMENT INFORMATION (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)RegionSegmentCountry	Dec. 31, 2014USD ($)
SEGMENT INFORMATION [Abstract]
Number of operating segments | Segment	1
Minimum percentage of revenue considered for accounted of major customer	10.00%
Number of countries in which company operates facilities | Country	13
Number of countries in which company sells products | Country	25
Number of regions in which company sells products | Region	3
Revenue from External Customer [Line Items]
Consolidated net sales shipped to customers	$ 180,300	$ 190,100
Percent of total revenue	100.00%	100.00%
Long-lived assets by country of domicile [Abstract]
Long-lived assets	$ 4,687	$ 4,103
Inventory, by Country [Abstract]
Inventories, net	9,199	10,591
Consolidated Product Sales [Member]
Revenue from External Customer [Line Items]
Consolidated net sales shipped to customers	143,100	155,300
Consolidated Pack Sales [Member]
Revenue from External Customer [Line Items]
Consolidated net sales shipped to customers	31,700	27,800
Consolidated Other, Including Freight [Member]
Revenue from External Customer [Line Items]
Consolidated net sales shipped to customers	5,500	7,000
Reportable Geographical Components [Member] | North America [Member]
Revenue from External Customer [Line Items]
Consolidated net sales shipped to customers	$ 73,300	$ 80,800
Percent of total revenue	40.70%	42.50%
Long-lived assets by country of domicile [Abstract]
Long-lived assets	$ 3,500	$ 3,100
Inventory, by Country [Abstract]
Inventories, net	3,400	4,000
Reportable Geographical Components [Member] | Asia/Pacific [Member]
Revenue from External Customer [Line Items]
Consolidated net sales shipped to customers	$ 91,400	$ 92,400
Percent of total revenue	50.70%	48.60%
Long-lived assets by country of domicile [Abstract]
Long-lived assets	$ 1,100	$ 800
Inventory, by Country [Abstract]
Inventories, net	4,300	4,300
Reportable Geographical Components [Member] | EMEA [Member]
Revenue from External Customer [Line Items]
Consolidated net sales shipped to customers	$ 15,600	$ 16,900
Percent of total revenue	8.60%	8.90%
Long-lived assets by country of domicile [Abstract]
Long-lived assets	$ 100	$ 200
Inventory, by Country [Abstract]
Inventories, net	$ 1,500	$ 2,300

SCHEDULE II - VALUATION AND Q62

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Allowance for Doubtful Accounts [Member]
Schedule of Valuation and Qualifying Accounts [Roll Forward]
Balance at beginning of year	$ 213	$ 142
Additions Charged to Costs and Expenses	369	579
Additions Charged to other Accounts	0	0
Deductions	(321)	(508)
Balance at end of year	261	213
Allowance for Obsolete Inventories [Member]
Schedule of Valuation and Qualifying Accounts [Roll Forward]
Balance at beginning of year	2,142	2,009
Additions Charged to Costs and Expenses	480	2,124
Additions Charged to other Accounts	0	0
Deductions	(1,357)	(1,991)
Balance at end of year	1,265	2,142
Valuation Allowance for Deferred Tax Assets [Member]
Schedule of Valuation and Qualifying Accounts [Roll Forward]
Balance at beginning of year	9,745	5,264
Additions Charged to Costs and Expenses	180	5,344
Additions Charged to other Accounts	0	0
Deductions	(897)	(863)
Balance at end of year	9,028	9,745
Reserve for Sales Returns [Member]
Schedule of Valuation and Qualifying Accounts [Roll Forward]
Balance at beginning of year	207	238
Additions Charged to Costs and Expenses	1,446	1,628
Additions Charged to other Accounts	0	0
Deductions	(1,506)	(1,659)
Balance at end of year	$ 147	$ 207